Wendy A. Woodward, M.D., Ph.D.

Peer-Reviewed Articles

1. Reddy, JP, Sherry, AD, Fellman, B, Liu, S, Bathala, TK, Haymaker, CL, Cohen, L, Smith, B, Ramirez, DL, Shaitelman, SF, Chun, SG, Medina-Rosales, M, Teshome, M, Brewster, A, Barcenas, CH, Reuben, A, Ghia, AJ, Ludmir, EB, Weed, D, Shah, SJ, Mitchell, MP, Woodward, W, Gomez, D, Tang, C. Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND). International Journal of Radiation Oncology Biology Physics 121(4):885-893, 2025. e-Pub 2025. PMID: 39486645.
2. Bendre SV, Wang Y, Hajyousif B, K C R, Bhogale SG, Pradeep D, Krawczynska N, Schane CP, Weisser E, Singh A, Han S, Kim H, Kockaya L, Gupta AD, Nelczyk AT, Gamage HEV, Fei Y, Guo X, Deaton RJ, Sverdlov M, Gann PH, Sinha S, Wang K, Van Bortle K, Tajkorshid E, Woodward WA, Cho W, Nelson ER. Cholesterol efflux protein, ABCA1, supports anti-cancer functions of myeloid immune cells. bioRxiv, 2025. e-Pub 2025. PMID: 40027727.
3. Woodward WA. Deescalation Perils in Inflammatory Breast Cancer. JAMA Netw Open 8(2):e2454513, 2025. e-Pub 2025. PMID: 40009389.
4. Shaitelman, SF, Le-Petross, H, Raso, G, Swanson, DM, Schalck, A, Contreras, A, Yang, F, Muruganandham, M, Zhao, GZ, Sawakuchi, GO, Kim, L, Batra, H, Smith, BD, Stauder, MC, Woodward, W, Reddy, JP, Litton, J, Thompson, A, Bedrosian, I, Mittendorf, EA. PRECISE. International Journal of Radiation Oncology Biology Physics 121(1):90-96, 2025. e-Pub 2025. PMID: 39147206.
5. Wang, X, Zhao, L, Song, X, Wu, X, Krishnamurthy, S, Semba, T, Shao, SH, Knafl, M, Coffer, LW, Alexander, A, Vines, A, Bopparaju, S, Woodward, W, Chu, RA, Zhang, J, Yam, C, Loo, LW, Nasrazadani, A, Huong, LP, Woodman, SE, Futreal, A, Zhang, S, Zhang, Q, Xu, M, Wistuba, II, Wang, W, Virani, S, Sun, B, Subramanya, S, Song, X, Song, P, Shaw, KR, Prabhakaran, S, Marques-Piubelli, ML, Mohammad, MM, Meric-Bernstam, F, Mendoza, MT, Mallampati, S, Lu, W, Little, L, Lang, W, Kinyua, W, Khanduri, I, Jiang, M, Jacob, J, Jackson, S, Gite, S, Garcia-Prieto, C, Arrechedera, C, Tripathy, D. Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer. npj Precision Oncology 8(1), 2024. e-Pub 2024. PMID: 39558017.
6. Valenza, C, Trapani, D, Zagami, P, Antonarelli, G, Boscolo Bielo, L, Nicolo, E, Ribeiro, JM, Guidi, L, Reduzzi, C, Spotti, M, Adamoli, L, Cortes, J, Pistilli, B, Tolaney, SM, Ueno, NT, Layman, RM, Cristofanilli, M, Carey, LA, Munzone, E, Criscitiello, C, Lynce, F, Woodward, W, Curigliano, G. Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE). European Journal of Cancer 213, 2024. e-Pub 2024. PMID: 39486164.
7. Jacomina LE, Swanson DM, Mitchell MP, Woodward WA, Smith BD, Hoffman KE, Goodman CR, Garber HR, Sun SX, Yap TA, Meric-Bernstam F, Arzu IY, Bloom ES, Schlembach PJ, Strom EA, Stauder MC, Shaitelman SF. Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer. Int J Radiat Oncol Biol Phys, 2024. e-Pub 2024. PMID: 39549757.
8. Glencer, AC, Wanis, KN, Brown, S, Lucci, A, Sun, SX, Adesoye, T, DeSnyder, SM, Layman, RM, Woodward, W, Hunt, KK, Teshome, M. Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership. Annals of surgical oncology 31(11):7326-7334, 2024. e-Pub 2024. PMID: 39034365.
9. Fu JB, Manne R, Ngo-Huang A, Tennison JM, Ng AH, Andersen C, Woodward WA, Bruera E. Onabotulinum toxin injections for shoulder and chest wall muscle pain in breast cancer survivors: retrospective study - preliminary report. BMJ Support Palliat Care, 2024. e-Pub 2024. PMID: 38839248.
10. Kumar S, Larson RA, Stecklein S, Reddy J, Debeb BG, Amos RA, Cologna SM, Woodward WA. In Vivo Simvastatin and Brain Radiation in a Model of HER2 (+) Inflammatory Breast Cancer Brain Metastasis. bioRxiv, 2024. e-Pub 2024. PMID: 38854130.
11. Yoder, AK, Xu, T, Youssef, P, DeSnyder, SM, Marqueen, KE, Isales, LE, Lin, R, Smith, B, Woodward, WA, Stauder, MC, Strom, EA, Aldrich, MB, Shaitelman, SF. Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast Cancer. Practical radiation oncology 14(3):e180-e189, 2024. e-Pub 2024. PMID: 37914083.
12. Schaverien, MV, Singh, P, Smith, B, Qiao, W, Akay, CL, Bloom, ES, Chavez Mac Gregor, M, Chu, CK, Clemens, MW, Colen, JS, Ehlers II, RA, Hwang, RF, Joyner, MM, Largo, RD, Mericli, AF, Mitchell, MP, Shuck, JW, Tamirisa, N, Tripathy, D, Villa, MT, Woodward, WA, Zacharia, R, Kuerer, HM, Hoffman, K. Premastectomy Radiotherapy and Immediate Breast Reconstruction. JAMA Network Open 7(4):E245217, 2024. e-Pub 2024. PMID: 38578640.
13. Nakhlis, F, Niman, SM, Ueno, NT, Troll, E, Ryan, S, Yeh, E, Warren, L, Bellon, JR, Harrison, BT, Iwase, T, Carisa Le-Petross, HT, Saleem, S, Teshome, M, Whitman, GJ, Woodward, WA, Overmoyer, BA, Tolaney, SM, Regan, MM, Lynce, F, Layman, RM. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer. Breast Cancer Research and Treatment 204(2):289-297, 2024. e-Pub 2024. PMID: 38155272.
14. Guhan, M, Crane, SM, Valerius, LS, Cruz, DL, Smith, B, Woodward, W, Mitchell, MP, Valero, V, Rauch, GM, Krishnamurthy, S, Warnecke, CL, Kuerer, HM, Shaitelman, SF. Patient Interest in Exploring Nonsurgical Treatment Approaches for Early-Stage Breast Cancer. International Journal of Radiation Oncology Biology Physics 118(2):443-454, 2024. e-Pub 2024. PMID: 37802228.
15. Whisenant MS, Alexander A, Woodward WA, Teshome M, Ueno NT, Williams LA. Inflammatory Breast Cancer: Understanding the Patient Experience. Cancer Nurs 47(1):E65-E72, 2024. e-Pub 2022. PMID: 36729801.
16. Balema, W, Morton, JE, Larson, R, Li, L, Velasquez, FC, Fowlkes, NW, Krishnamurthy, S, Debeb, BG, Sevick-Muraca, EM, Woodward, W. High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells. Journal of Mammary Gland Biology and Neoplasia 28(1), 2023. e-Pub 2023. PMID: 37801190.
17. Gadde, M, Mehrabi-Dehdezi, M, Debeb, BG, Woodward, W, Rylander, MN. Influence of Macrophages on Vascular Invasion of Inflammatory Breast Cancer Emboli Measured Using an In Vitro Microfluidic Multi-Cellular Platform. Cancers 15(19), 2023. e-Pub 2023. PMID: 37835577.
18. Adesoye, T, Everidge, S, Chen, J, Sun, SX, Teshome, M, Valero, V, Woodward, W, Lucci, A. ASO Visual Abstract. Annals of surgical oncology 30(10):6241-6242, 2023. e-Pub 2023. PMID: 37578608.
19. Adesoye, T, Everidge, S, Chen, J, Sun, SX, Teshome, M, Valero, V, Woodward, W, Lucci, A. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Annals of surgical oncology 30(10):6232-6240, 2023. e-Pub 2023. PMID: 37479842.
20. Adesoye, T, Everidge, S, Chen, J, Sun, SX, Teshome, M, Valero, V, Woodward, W, Lucci, A. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Annals of surgical oncology 30(10):6232-6240, 2023. e-Pub 2023. PMID: 37479842.
21. Adesoye, T, Everidge, S, Chen, J, Sun, SX, Teshome, M, Valero, V, Woodward, W, Lucci, A. ASO Visual Abstract. Annals of surgical oncology 30(10):6241-6242, 2023. e-Pub 2023. PMID: 37578608.
22. Adesoye, T, Everidge, S, Chen, J, Sun, SX, Teshome, M, Valero, V, Woodward, W, Lucci, A. ASO Visual Abstract. Annals of surgical oncology 30(10):6241-6242, 2023. e-Pub 2023. PMID: 37578608.
23. Litton JK, Regan MM, Pusztai L, Rugo HS, Tolaney SM, Garrett-Mayer E, Amiri-Kordestani L, Basho RK, Best AF, Boileau JF, Denkert C, Foster JC, Harbeck N, Jacene HA, King TA, Mason G, O'Sullivan CC, Prowell TM, Richardson AL, Sepulveda KA, Smith ML, Tjoe JA, Turashvili G, Woodward WA, Butler LP, Schwartz EI, Korde LA. Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP. J Clin Oncol 41(27):JCO2300435, 2023. e-Pub 2023. PMID: 37433103.
24. Jagsi R, Barlow WE, Woodward WA, Connolly E, Mahtani R, Shumway D, Speers C, Stecklein SR, Zeidan Y, Zhang H, Sharma P, Pusztai L, Hortobagyi GN, Kalinsky K. Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial. JAMA Oncol 9(8):1083-1089, 2023. e-Pub 2023. PMID: 37410451.
25. Tarek A, Mohamed HT, El-Sharkawy AA, El-Sayed SK, Hirshon JM, Woodward WA, El-Shinawi M, Mohamed MM. Differential gene expression of Fresh Tissue and Patient-Derived Explants' Matricellular Proteins Augment Inflammatory Breast Cancer Metastasis: The Possible Role of IL-6 and MCP-1. QJM 116(5):345-354, 2023. e-Pub 2023. PMID: 36592055.
26. Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast 68:205-215, 2023. e-Pub 2023. PMID: 36863241.
27. Chmura SJ, Woodward WA, White JR. Reply to J. Widder. J Clin Oncol 41(4):JCO2201764, 2023. e-Pub 2023. PMID: 36288507.
28. Woodward WA, Mitchell MP. The Elusive Prize of Radiation Therapy Predictive Assays in Breast Cancer. Int J Radiat Oncol Biol Phys 115(1):103-105, 2023. e-Pub 2023. PMID: 36526377.
29. Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol 29(Suppl 3):620-621, 2022. e-Pub 2022. PMID: 36104531.
30. Corrigan KL, Kouzy R, Jaoude JA, Patel RR, Layman RM, Giordano SH, Woodward WA, Smith BD, Shaitelman SF, Ludmir EB. Inclusion of premenopausal women in breast cancer clinical trials. Breast 66:204-207, 2022. e-Pub 2022. PMID: 36327626.
31. Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol 29(10):6370-6378, 2022. e-Pub 2022. PMID: 35854031.
32. Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol 29(10):6381-6392, 2022. e-Pub 2022. PMID: 35834145.
33. Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol 29(10):6379-6380, 2022. e-Pub 2022. PMID: 36030283.
34. Sittenfeld SMC, Zabor EC, Hamilton SN, Kuerer HM, El-Tamer M, Naoum GE, Truong PT, Nichol A, Smith BD, Woodward WA, Moo TA, Powell SN, Shah CS, Taghian AG, Abu-Gheida I, Tendulkar RD. A multi-institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1-2N1 breast cancer. Cancer 128(16):3057-3066, 2022. e-Pub 2022. PMID: 35713598.
35. Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat 195(1):33-41, 2022. e-Pub 2022. PMID: 35816269.
36. Adesoye T, Sun SX, Schaverien MV, Woodward WA, Lucci A. Immediate Breast Reconstruction in Inflammatory Breast Cancer: Are We There Yet?. Ann Surg Oncol 29(7):4019-4021, 2022. e-Pub 2022. PMID: 35471749.
37. Andring LM, Diao K, Sun S, Patel M, Whitman GJ, Schlembach P, Arzu I, Joyner MM, Shaitelman SF, Hoffman K, Stauder MC, Smith BD, Woodward WA. Locoregional Management and Prognostic Factors in Breast Cancer Patients with Ipsilateral Internal Mammary and Axillary Lymph Node Involvement. Int J Radiat Oncol Biol Phys 113(3):552-560, 2022. e-Pub 2022. PMID: 35248602.
38. Tarek, A, El-Sayed, SK, Woodward, W, El-Shinawi, M, Hirshon, JM, Mohamed, MM. Inflammatory Breast Cancer. Current Issues in Molecular Biology 44(6):2730-2744, 2022. e-Pub 2022. PMID: 35735628.
39. Jagsi R, Mason G, Overmoyer BA, Woodward WA, Badve S, Schneider RJ, Lang JE, Alpaugh M, Williams KP, Vaught D, Smith A, Smith K, Miller KD, Milburn Foundation SGKICIPWT. Correction to: Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research. Breast Cancer Res Treat 192(2):245-247, 2022. e-Pub 2022. PMID: 35133550.
40. Jagsi R, Mason G, Overmoyer BA, Woodward WA, Badve S, Schneider RJ, Lang JE, Alpaugh M, Williams KP, Vaught D, Smith A, Smith K, Miller KD, Milburn Foundation SGKICIPWT. Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research. Breast Cancer Res Treat 192(2):235-243, 2022. e-Pub 2022. PMID: 34973083.
41. Villodre ES, Hu X, Eckhardt BL, Larson R, Huo L, Yoon EC, Gong Y, Song J, Liu S, Ueno NT, Krishnamurthy S, Pusch S, Tripathy D, Woodward WA, Debeb BG. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis. J Natl Cancer Inst 114(4):579-591, 2022. e-Pub 2022. PMID: 34893874.
42. Corrigan KL, Lei X, Ahmad N, Arzu I, Bloom E, Chun SG, Goodman C, Hoffman KE, Joyner M, Mayo L, Mitchell M, Nead KT, Perkins GH, Reed V, Reddy JP, Schlembach P, Shaitelman SF, Stauder MC, Strom EA, Tereffe W, Wiederhold L, Woodward WA, Smith BD. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer. Adv Radiat Oncol 7(2):100877, 2022. e-Pub 2022. PMID: 35387420.
43. Sosa A, Lei X, Woodward WA, Chavez Mac Gregor M, Lucci A, Giordano SH, Nead KT. Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US. JAMA Netw Open 5(2):e2148021, 2022. e-Pub 2022. PMID: 35147686.
44. Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Outcomes after breast radiotherapy in a diverse patient cohort with a germline BRCA1/2 mutation. Int J Radiat Oncol Biol Phys 112(2):426-436, 2022. e-Pub 2022. PMID: 34610390.
45. Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Breast radiotherapy-related treatment outcomes in patients with or without germline mutations on multigene panel testing. Int J Radiat Oncol Biol Phys 112(2):437-444, 2022. e-Pub 2022. PMID: 34582940.
46. Rypens C, Bertucci F, Finetti P, Robertson F, Fernandez SV, Ueno N, Woodward WA, Van Golen K, Vermeulen P, Dirix L, Viens P, Birnbaum D, Devi GR, Cristofanilli M, Van Laere S. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. NPJ Breast Cancer 8(1):12, 2022. e-Pub 2022. PMID: 35042871.
47. Diao K, Andring LM, Barcenas CH, Singh P, Carisa Le-Petross H, Reed VK, Reddy JP, Bloom ES, Ahmad NR, Mayo LL, Perkins GH, Mitchell MP, Nead KT, Tereffe W, Smith BD, Woodward WA. Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement. Int J Radiat Oncol Biol Phys 112(1):66-74, 2022. e-Pub 2022. PMID: 34710521.
48. Kolonin MG, Woodward WA. Chemotherapy Triggers T Cells to Remodel the Extracellular Matrix and Promote Metastasis. Cancer Res 82(2):197-198, 2022. e-Pub 2022. PMID: 35042745.
49. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol 28(13):8610-8621, 2021. e-Pub 2021. PMID: 34125346.
50. Le-Petross HT, Balema W, Woodward WA. Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review. Chin Clin Oncol 10(6):58, 2021. e-Pub 2021. PMID: 35016512.
51. Corrigan KL, Woodward WA, Stauder MC. How should radiation be done for inflammatory breast cancer patients?-a narrative review of modern literature. Chin Clin Oncol 10(6):60, 2021. e-Pub 2021. PMID: 35016514.
52. McCormick B, Winter KA, Woodward W, Kuerer HM, Sneige N, Rakovitch E, Smith BL, Germain I, Hartford AC, O'Rourke MA, Walker EM, Strom EA, Hopkins JO, Pierce LJ, Pu AT, Sumida KNM, Vesprini D, Moughan J, White JR. Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804. J Clin Oncol 39(32):3574-3582, 2021. e-Pub 2021. PMID: 34406870.
53. Nowakowska MK, Lei X, Thompson MT, Shaitelman SF, Wehner MR, Woodward WA, Giordano SH, Nead KT. Association of statin use with clinical outcomes in patients with triple-negative breast cancer. Cancer 127(22):4142-4150, 2021. e-Pub 2021. PMID: 34342892.
54. Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt KK, Lucci A, Teshome M. Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol 28(10):5626-5634, 2021. e-Pub 2021. PMID: 34292426.
55. Villodre ES, Hu X, Larson R, Finetti P, Gomez K, Balema W, Stecklein SR, Santiago-Sanchez G, Krishnamurthy S, Song J, Su X, Ueno NT, Tripathy D, Van Laere S, Bertucci F, Vivas-Mejía P, Woodward WA, Debeb BG. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Mol Oncol 15(10):2752-2765, 2021. e-Pub 2021. PMID: 34342930.
56. Weng JK, Lei X, Schlembach P, Bloom ES, Shaitelman SF, Arzu IY, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys 111(2):360-370, 2021. e-Pub 2021. PMID: 33992718.
57. Balema W, Liu D, Shen Y, El-Zein R, Debeb BG, Kai M, Overmoyer B, Miller KD, Le-Petross HT, Ueno NT, Woodward WA. Inflammatory breast cancer appearance at presentation is associated with overall survival. Cancer Med 10(18):6261-6272, 2021. e-Pub 2021. PMID: 34327874.
58. Partain, NS, Postlewait, LM, Teshome, M, Rosso, KJ, Hall, CS, Song, J, Meas, S, DeSnyder, SM, Lim, B, Valero, V, Woodward, W, Ueno, NT, Kuerer, HM, Lucci, A. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Annals of surgical oncology 28(8):4265-4274, 2021. e-Pub 2021. PMID: 33403525.
59. Boyce-Fappiano D, Bedrosian I, Shen Y, Lin H, Gjyshi O, Yoder A, Shaitelman SF, Woodward WA. Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis. NPJ Breast Cancer 7(1):87, 2021. e-Pub 2021. PMID: 34226566.
60. Liveringhouse CL, Washington IR, Diaz R, Jimenez RB, Harris EE, Rabinovitch R, Woodward WA, Torres-Roca JF, Ahmed KA. Genomically Guided Breast Radiation Therapy: A Review of the Current Data and Future Directions. Adv Radiat Oncol 6(4):100731, 2021. e-Pub 2021. PMID: 34409215.
61. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. ASO Visual Abstract: Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. e-Pub 2021. PMID: 34052918.
62. Li X, Kumar S, Harmanci A, Li S, Kitchen RR, Zhang Y, Wali VB, Reddy SM, Woodward WA, Reuben JM, Rozowsky J, Hatzis C, Ueno NT, Krishnamurthy S, Pusztai L, Gerstein M. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers. Genome Med 13(1):70, 2021. e-Pub 2021. PMID: 33902690.
63. Chakraborty P, George JT, Woodward WA, Levine H, Jolly MK. Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum. Transl Oncol 14(4):101026, 2021. e-Pub 2021. PMID: 33535154.
64. Coroneos CJ, Woodward WA, Wong FC, Caudle AS, Shaitelman SF, Kuerer HM, Schaverien MV. Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer. J Surg Oncol 123(4):846-853, 2021. e-Pub 2021. PMID: 33333583.
65. Pasalic D, Strom EA, Allen PK, Williamson TD, Poenisch F, Amos RA, Woodward WA, Stauder MC, Shaitelman SF, Smith BD, Perkins GH, Tereffe W, Hoffman KE. Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase II Trial. Int J Radiat Oncol Biol Phys 109(2):441-448, 2021. e-Pub 2021. PMID: 32946965.
66. Hu X, Villodre ES, Woodward WA, Debeb BG. Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells. J Vis Exp(168), 2021. e-Pub 2021. PMID: 33616115.
67. Smith DL, Debeb BG, Diagaradjane P, Larson R, Kumar S, Ning J, Lacerda L, Li L, Woodward WA. Prophylactic cranial irradiation reduces the incidence of brain metastasis in a mouse model of metastatic, HER2-positive breast cancer. Genes Cancer 12:28-38, 2021. e-Pub 2021. PMID: 33884104.
68. Hu X, Villodre ES, Larson R, Rahal OM, Wang X, Gong Y, Song J, Krishnamurthy S, Ueno NT, Tripathy D, Woodward WA, Debeb BG. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol 4(1):72, 2021. e-Pub 2021. PMID: 33452400.
69. Villodre ES, Gong Y, Hu X, Huo L, Yoon EC, Ueno NT, Woodward WA, Tripathy D, Song J, Debeb BG. NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer. Cancers (Basel) 12(12), 2020. e-Pub 2020. PMID: 33321961.
70. Reiner AS, Robson ME, Mellemkjær L, Tischkowitz M, John EM, Lynch CF, Brooks JD, Boice JD, Knight JA, Teraoka SN, Liang X, Woods M, Shen R, Shore RE, Stram DO, Thomas DC, Malone KE, Bernstein L, Riaz N, Woodward W, Powell S, Goldgar D, Concannon P, Collaborative Group WS, Bernstein JL. Radiation treatment, ATM, BRCA1/2, and CHEK2*1100delC pathogenic variants, and risk of contralateral breast cancer. J Natl Cancer Inst 112(12):1275-1279, 2020. e-Pub 2020. PMID: 32119081.
71. Postlewait LM, Teshome M, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Woodward WA, Ueno NT, Lucci A. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?. Ann Surg Oncol 27(12):4603-4612, 2020. e-Pub 2020. PMID: 32710271.
72. Gadde M, Phillips C, Ghousifam N, Sorace AG, Wong E, Krishnamurthy S, Syed A, Rahal O, Yankeelov TE, Woodward WA, Rylander MN. In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer. Biotechnol Bioeng 117(11):3572-3590, 2020. e-Pub 2020. PMID: 32648934.
73. Yu JB, Brock KK, Campbell AM, Chen AB, Diaz R, Escorcia FE, Gupta G, Hrinivich WT, Joseph S, Korpics M, Onderdonk BE, Pandit-Taskar N, Wood BJ, Woodward WA. Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop. Int J Radiat Oncol Biol Phys 108(3):539-545, 2020. e-Pub 2020. PMID: 32434040.
74. Kida K, Hess KR, Lim B, Iwase T, Chainitikun S, Valero V, Lucci A, Le-Petross HC, Woodward WA, Krishnamurthy S, Hortobagyi GN, Tripathy D, Ueno NT. Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer. Cancers (Basel) 12(11), 2020. e-Pub 2020. PMID: 33114311.
75. Hoffman KE, Garner D, Koong AC, Woodward WA. Understanding the Intersection of Working from Home and Burnout to Optimize Post-COVID19 Work Arrangements in Radiation Oncology. Int J Radiat Oncol Biol Phys 108(2):370-373, 2020. e-Pub 2020. PMID: 32890515.
76. Mohamed HT, El-Ghonaimy EA, El-Shinawi M, Hosney M, Götte M, Woodward WA, El-Mamlouk T, Mohamed MM. IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2. Toxicol Appl Pharmacol 401:115092, 2020. e-Pub 2020. PMID: 32512068.
77. Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 5(4):567-572, 2020. e-Pub 2020. PMID: 32775771.
78. Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Piotrowski M, Fuller CD, Stauder MC, Shaitelman SF, Perkins GH, Woodward WA, Giordano SH, Smith BD, Ludmir EB. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. Oncologist 25(6):e990-e992, 2020. e-Pub 2020. PMID: 32272505.
79. Grant SR, Krishnamurthy S, Le-Petross C, Valero V, Teshome M, Woodward WA. An inflammatory imposter: Three cases of Mullerian carcinoma appearing as inflammatory breast cancer. Breast J 26(5):1022-1024, 2020. e-Pub 2020. PMID: 31960546.
80. Iwase T, Harano K, Masuda H, Kida K, Hess KR, Wang Y, Dirix L, Van Laere SJ, Lucci A, Krishnamurthy S, Woodward WA, Layman RM, Bertucci F, Ueno NT. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC. BMC Cancer 20(1):430, 2020. e-Pub 2020. PMID: 32423453.
81. Woodward WA, Barlow WE, Jagsi R, Buchholz TA, Shak S, Baehner F, Whelan TJ, Davidson NE, Ingle JN, King TA, Ravdin PM, Osborne CK, Tripathy D, Livingston RB, Gralow JR, Hortobagyi GN, Hayes DF, Albain KS. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. JAMA Oncol 6(4):505-511, 2020. e-Pub 2020. PMID: 31917424.
82. Woodward WA. Building momentum for subsets of patients with advanced triple-negative breast cancer. Lancet Oncol 21(1):3-5, 2020. e-Pub 2020. PMID: 31786122.
83. Stecklein SR, Rosso KJ, Nuanjing J, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Teshome M, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA. Excellent Locoregional Control in Inflammatory Breast Cancer with a Personalized Radiotherapy Approach. Pract Radiat Oncol 9(6):402-409, 2019. e-Pub 2019. PMID: 31132433.
84. Arthur DW, Winter KA, Kuerer HM, Haffty B, Cuttino L, Todor DA, Anne PR, Anderson P, Woodward WA, McCormick B, Cheston S, Sahijdak WM, Canaday D, Brown DR, Currey A, Fisher CM, Jagsi R, Moughan J, White JR. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial. JAMA Oncol. e-Pub 2019. PMID: 31750868.
85. Fujii T, Mason J, Chen A, Kuhn P, Woodward WA, Tripathy D, Newton PK, Ueno NT. Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model. Oncologist 24(10):1322-1330, 2019. e-Pub 2019. PMID: 30952823.
86. Cohen EN, Fouad TM, Lee BN, Arun BK, Liu D, Tin S, Gutierrez Barrera AM, Miura T, Kiyokawa I, Yamashita J, Alvarez RH, Valero V, Woodward WA, Shen Y, Ueno NT, Cristofanilli M, Reuben JM. Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer. Breast Cancer Res Treat 176(3):545-556, 2019. e-Pub 2019. PMID: 31054033.
87. Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of curative-intent treatment for breast cancer patients presenting with sternal or mediastinal involvement. Int J Radiat Oncol Biol Phys 104(3):574-581, 2019. e-Pub 2019. PMID: 30851348.
88. Reddy SM, Reuben A, Barua S, Jiang H, Zhang S, Wang L, Gopalakrishnan V, Hudgens CW, Tetzlaff MT, Reuben JM, Tsujikawa T, Coussens LM, Wani K, He Y, Villareal L, Wood A, Rao A, Woodward WA, Ueno NT, Krishnamurthy S, Wargo JA, Mittendorf EA. Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer. Cancer Immunol Res 7(6):1025-1035, 2019. e-Pub 2019. PMID: 31043414.
89. McGee HM, Jiang D, Soto-Pantoja DR, Nevler A, Giaccia AJ, Woodward WA. Targeting the Tumor Microenvironment in Radiation Oncology: Proceedings from the 2018 ASTRO-AACR Research Workshop. Clin Cancer Res 25(10):2969-2974, 2019. e-Pub 2019. PMID: 30723144.
90. Stecklein SR, Shaitelman SF, Babiera GV, Bedrosian I, Black DM, Ballo MT, Arzu I, Strom EA, Reed VK, Dvorak T, Smith BD, Woodward WA, Hoffman KE, Schlembach PJ, Kirsner SM, Nelson CL, Yang J, Guerra W, Dibaj S, Bloom ES. Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation with Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy. Pract Radiat Oncol 9(1):e4-e13, 2019. e-Pub 2019. PMID: 30125673.
91. Devi, GR, Hough, H, Barrett, N, Cristofanilli, M, Overmoyer, BA, Spector, NL, Ueno, NT, Woodward, W, Kirkpatrick, JP, Vincent, BG, Williams, KP, Finley, C, Duff, B, Worthy, V, McCall, S, Hollister, BA, Palmer, G, Force, J, Westbrook, KE, Fayanju, OM, Suneja, G, Dent, S, Hwang, ES, Patierno, SR, Marcom, PK. Perspectives on inflammatory breast cancer (IBC) research, clinical management and community engagement from the duke IBC consortium. Journal of Cancer 10(15):3344-3351, 2019. e-Pub 2019. PMID: 31293637.
92. Ning J, Fouad TM, Lin H, Sahin AA, Lucci A, Woodward WA, Krishnamurthy S, Tripathy D, Ueno NT, Shen Y. The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer. J Cancer 10(12):2635-2642, 2019. e-Pub 2019. PMID: 31258771.
93. Chakraborty S, Ozkan A, Rylander MN, Woodward WA, Vlachos P. Mixture theory modeling for characterizing solute transport in breast tumor tissues. J Biol Eng 13:46, 2019. e-Pub 2019. PMID: 31160921.
94. Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol 4(12):1751-1757, 2018. e-Pub 2018. PMID: 30027292.
95. Stecklein SR, Park M, Liu DD, Valle Goffin JJ, Caudle AS, Mittendorf EA, Barcenas CH, Mougalian S, Woodward WA, Valero V, Sahin AA, Yang WT, Shaitelman SF. Long-Term Impact of Regional Nodal Irradiation in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy. Int J Radiat Oncol Biol Phys 102(3):568-577, 2018. e-Pub 2018. PMID: 29928946.
96. Craft, DF, Balter, PA, Woodward, W, Kry, SF, Salehpour, M, Ger, R, Peters, M, Baltz, G, Traneus, E, Howell, RM. Design, fabrication, and validation of patient-specific electron tissue compensators for postmastectomy radiation therapy. Physics and Imaging in Radiation Oncology 8:38-43, 2018. e-Pub 2018. PMID: 33458415.
97. Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol:JCO1800317. e-Pub 2018. PMID: 30379626.
98. Reddy JP, Atkinson RL, Larson R, Burks JK, Smith D, Debeb BG, Ruffell B, Creighton CJ, Bambhroliya A, Reuben JM, Van Laere SJ, Krishnamurthy S, Symmans WF, Brewster AM, Woodward WA. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. Breast Cancer Res Treat 171(2):283-293, 2018. e-Pub 2018. PMID: 29858753.
99. Matsuda N, Wang X, Lim B, Krishnamurthy S, Alvarez RH, Willey JS, Parker CA, Song J, Shen Y, Hu J, Wu W, Li N, Babiera GV, Murray JL, Arun BK, Brewster AM, Reuben JM, Stauder MC, Barnett CM, Woodward WA, Le-Petross HTC, Lucci A, DeSnyder SM, Tripathy D, Valero V, Ueno NT. Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer. JAMA Oncol 4(9):1207-1213, 2018. e-Pub 2018. PMID: 29879283.
100. Li A, Barsoumian HB, Schoenhals JE, Cushman TR, Caetano MS, Wang X, Valdecanas DR, Niknam S, Younes AI, Li G, Woodward WA, Cortez MA, Welsh JW. Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells. Cancer Lett 431:54-63, 2018. e-Pub 2018. PMID: 29746927.
101. Uemura MI, French JT, Hess KR, Liu D, Raghav K, Hortobagyi GN, Arun BK, Valero V, Ueno NT, Alvarez RH, Woodward WA, Debeb BG, Moulder SL, Lim B, Tripathy D, Ibrahim NK. Development of CNS metastases and survival in patients with inflammatory breast cancer. Cancer 124(11):2299-2305, 2018. e-Pub 2018. PMID: 29579338.
102. Weiss A, Menen RS, Lin HY, Shen Y, Rosso KJ, Shaitelman S, Woodward WA, Valero V, Ueno NT, Bedrosian I, Babiera G. Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Res Treat 169(3):615-623, 2018. e-Pub 2018. PMID: 29460033.
103. Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho A, Feng FY, Speers C, Overmoyer B, Sabel M, Schott AF, Pierce L, Research Consortium TBC. Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study. J Clin Oncol 36(13):1317-1322, 2018. e-Pub 2018. PMID: 29558281.
104. Ovalle V, Strom EA, Shaitelman S, Hoffman K, Amos R, Perkins G, Tereffe W, Smith BD, Stauder M, Woodward WA. Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects. Cancers (Basel) 10(4), 2018. e-Pub 2018. PMID: 29642467.
105. Craft DF, Kry SF, Balter P, Salehpour M, Woodward WA, Howell RM. Material Matters: Analysis of Density Uncertainty in 3D Printing and its Consequences for Radiation Oncology. Med Phys 45(4):1614-1621, 2018. e-Pub 2018. PMID: 29493803.
106. Rahal OM, Wolfe AR, Mandal PK, Larson R, Tin S, Jimenez C, Zhang D, Horton J, Reuben JM, McMurray JS, Woodward WA. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys 100(4):1034-1043, 2018. e-Pub 2018. PMID: 29485045.
107. Caceres S, Monsalve B, Peña L, de Andres PJ, Alonso-Diez A, Illera MJ, Woodward WA, Reuben JM, Silvan G, Illera JC. In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines. Vet Comp Oncol 16(1):148-158, 2018. e-Pub 2018. PMID: 28589573.
108. DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, Woodward WA, Kuerer HM, Akay CL, Babiera GV, Yang W, Lucci A. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer. Clin Breast Cancer 18(1):e73-e77, 2018. e-Pub 2018. PMID: 28755879.
109. Harano K, Wang Y, Lim B, Seitz RS, Morris SW, Bailey DB, Hout DR, Skelton RL, Ring BZ, Masuda H, Rao AUK, Laere SV, Bertucci F, Woodward WA, Reuben JM, Krishnamurthy S, Ueno NT. Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype. PLoS One 13(10):e0204513, 2018. e-Pub 2018. PMID: 30312311.
110. Tripathi S, Jolly MK, Woodward WA, Levine H, Deem MW. Analysis of Hierarchical Organization in Gene Expression Networks Reveals Underlying Principles of Collective Tumor Cell Dissemination and Metastatic Aggressiveness of Inflammatory Breast Cancer. Front Oncol 8:244, 2018. e-Pub 2018. PMID: 30023340.
111. Bambhroliya A, Van Wyhe RD, Kumar S, Debeb BG, Reddy JP, Van Laere S, El-Zein R, Rao A, Woodward WA. Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer. PLoS One 13(4):e0192689, 2018. e-Pub 2018. PMID: 29617367.
112. Fouad TM, Ueno NT, Yu RK, Ensor JE, Alvarez RH, Krishnamurthy S, Lucci A, Reuben JM, Yang W, Willey JS, Valero V, Bondy ML, Cristofinalli M, Shete S, Woodward WA, El-Zein R. Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center. PLoS One 13(9):e0204372, 2018. e-Pub 2018. PMID: 30248155.
113. Woodward WA, Fang P, Arriaga L, Gao H, Cohen EN, Reuben JM, Valero V, Le-Petross H, Middleton LP, Babiera GV, Strom EA, Tereffe W, Hoffman K, Smith BD, Buchholz TA, Perkins GH. A Phase 2 Study of Preoperative Capecitabine and Concomitant Radiation in Women With Advanced Breast Cancer. Int J Radiat Oncol Biol Phys 99(4):777-783, 2017. e-Pub 2017. PMID: 28843370.
114. Caceres S, Peña L, Lacerda L, Illera MJ, de Andres PJ, Larson RA, Gao H, Debeb BG, Woodward WA, Reuben JM, Illera JC. Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer. Vet Comp Oncol 15(3):980-995, 2017. e-Pub 2017. PMID: 27146723.
115. Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys 98(5):1028-1035, 2017. e-Pub 2017. PMID: 28721885.
116. Rosso KJ, Tadros AB, Weiss A, Warneke CL, DeSnyder S, Kuerer H, Ueno NT, Stecklein SR, Woodward WA, Lucci A. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery. Ann Surg Oncol. e-Pub 2017. PMID: 28766220.
117. Kuerer HM, Smith BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward WA, Tripathy D, Yang WT, Hunt KK. DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes. J Cancer 8(14):2653-2662, 2017. e-Pub 2017. PMID: 28928852.
118. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol. e-Pub 2017. PMID: 28766219.
119. Wang X, Reyes ME, Zhang D, Funakoshi Y, Trape AP, Gong Y, Kogawa T, Eckhardt BL, Masuda H, Pirman DA, Yang P, Reuben JM, Woodward WA, Bartholomeusz C, Hortobagyi GN, Tripathy D, Ueno NT. EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer. Oncotarget 8(40):67904-67917, 2017. e-Pub 2017. PMID: 28978083.
120. Moreno AC, Lin YH, Bedrosian I, Shen Y, Stauder MC, Smith BD, Buchholz TA, Babiera GV, Woodward WA, Shaitelman SF. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis. Adv Radiat Oncol 2(3):291-300, 2017. e-Pub 2017. PMID: 29114595.
121. Rosso KJ, Ueno NT, Woodward WA, Lucci A. In response to "outcomes of patients with inflammatory breast cancer treated by breast conserving surgery": the argument against breast conservation and sentinel lymph node biopsy in IBC. Breast Cancer Res Treat. e-Pub 2017. PMID: 28674763.
122. Matsuda N, Lim B, Wang Y, Krishnamurthy S, Woodward WA, Alvarez RH, Lucci A, Valero V, Reuben JM, Meric-Bernstam F, Ueno NT. Identification of frequent somatic mutations in inflammatory breast cancer. Breast Cancer Res Treat 163(2):263-272, 2017. e-Pub 2017. PMID: 28243898.
123. Mego M, Gao H, Cohen EN, Anfossi S, Giordano A, Tin S, Fouad TM, De Giorgi U, Giuliano M, Woodward WA, Alvarez RH, Valero V, Ueno NT, Hortobagyi GN, Cristofanilli M, Reuben JM. Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer. Oncotarget 8(22):35656-35668, 2017. e-Pub 2017. PMID: 27374101.
124. Reyes ME, Fujii T, Branstetter D, Krishnamurthy S, Masuda H, Wang X, Reuben JM, Woodward WA, Edwards BJ, Hortobagyi GN, Tripathy D, Dougall WC, Eckhardt BL, Ueno NT. Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression. Breast Cancer Res Treat. e-Pub 2017. PMID: 28417335.
125. Putcha P, Yu J, Rodriguez-Barrueco R, Saucedo-Cuevas L, Villagrasa P, Murga-Penas E, Quayle SN, Yang M, Castro V, Llobet-Navas D, Birnbaum D, Finetti P, Woodward WA, Bertucci F, Alpaugh ML, Califano A, Silva J. Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers. Breast Cancer Res 19(1):49, 2017. e-Pub 2017. PMID: 28424080.
126. Shaitelman SF, Chiang YJ, Griffin KD, DeSnyder SM, Smith BD, Schaverien MV, Woodward WA, Cormier JN. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat 162(2):201-215, 2017. e-Pub 2017. PMID: 28012086.
127. Shaitelman SF, Chiang YJ, Griffin KD, De Snyder SM, Smith BD, Schaverien MV, Woodward WA, Cormier JN. Erratum to: Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat 162(2):217, 2017. e-Pub 2017. PMID: 28185145.
128. Fouad TM, Barrera AM, Reuben JM, Lucci A, Woodward WA, Stauder MC, Lim B, DeSnyder SM, Arun B, Gildy B, Valero V, Hortobagyi GN, Ueno NT. Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system. Lancet Oncol 18(4):e228-e232, 2017. e-Pub 2017. PMID: 28368261.
129. Vila J, Teshome M, Tucker SL, Woodward WA, Chavez-MacGregor M, Hunt KK, Mittendorf EA. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg 265(3):574-580, 2017. e-Pub 2017. PMID: 27735826.
130. Lin HY, Bedrosian I, Babiera GV, Shaitelman SF, Kuerer HM, Woodward WA, Ueno NT, Shen Y. Using the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer. Cancer. e-Pub 2017. PMID: 28295213.
131. Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, El-Zein R, Rahal OM, Alexander A, Reuben JM, Krishnamurthy S, Lucci A, Ueno NT. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference. J Cancer 8(17):3607-3614, 2017. e-Pub 2017. PMID: 29667990.
132. Jolly MK, Boareto M, Debeb BG, Aceto N, Farach-Carson MC, Woodward WA, Levine H. Inflammatory breast cancer: a model for investigating cluster-based dissemination. NPJ Breast Cancer 3:21, 2017. e-Pub 2017. PMID: 28649661.
133. Shaitelman SF, Stauder MC, Allen P, Reddy S, Lakoski S, Atkinson B, Reddy J, Amaya D, Guerra W, Ueno N, Caudle A, Tereffe W, Woodward WA. Impact of Statin Use on Outcomes in Triple Negative Breast Cancer. J Cancer 8(11):2026-2032, 2017. e-Pub 2017. PMID: 28819403.
134. Stecklein SR, Reddy JP, Wolfe AR, Lopez MS, Fouad TM, Debeb BG, Ueno NT, Brewster AM, Woodward WA. Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival. J Cancer 8(10):1726-1732, 2017. e-Pub 2017. PMID: 28819368.
135. Van Wyhe RD, Rahal OM, Woodward WA. Effect of statins on breast cancer recurrence and mortality: a review. Breast Cancer (Dove Med Press) 9:559-565, 2017. e-Pub 2017. PMID: 29238220.
136. Stauder MC, Caudle AS, Allen PK, Shaitelman SF, Smith BD, Hoffman KE, Buchholz TA, Chavez-Macgregor M, Hunt KK, Meric-Bernstam F, Woodward WA. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys 96(3):637-644, 2016. e-Pub 2016. PMID: 27681760.
137. Wolfe AR, Trenton NJ, Debeb BG, Larson R, Ruffell B, Chu K, Hittelman W, Diehl M, Reuben JM, Ueno NT, Woodward WA. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models. Oncotarget. e-Pub 2016. PMID: 27756885.
138. Dobroff AS, D'Angelo S, Eckhardt BL, Ferrara F, Staquicini DI, Cardó-Vila M, Staquicini FI, Nunes DN, Kim K, Driessen WH, Hajitou A, Lomo LC, Barry M, Krishnamurthy S, Sahin A, Woodward WA, Prossnitz ER, Anderson RL, Dias-Neto E, Brown-Glaberman UA, Royce ME, Ueno NT, Cristofanilli M, Hortobagyi GN, Marchiò S, Gelovani JG, Sidman RL, Arap W, Pasqualini R. Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes. Proc Natl Acad Sci U S A. e-Pub 2016. PMID: 27791177.
139. Smith DL, Debeb BG, Thames HD, Woodward WA. Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response. Int J Radiat Oncol Biol Phys 96(1):179-87, 2016. e-Pub 2016. PMID: 27511855.
140. Swanick CW, Lei X, Shaitelman SF, Schlembach PJ, Bloom ES, Fingeret MC, Strom EA, Tereffe W, Woodward WA, Stauder MC, Dvorak T, Thompson AM, Buchholz TA, Smith BD. Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated versus Hypofractionated Whole-Breast Irradiation. Cancer 122(18):2886-2894, 2016. e-Pub 2016. PMID: 27305037.
141. Loveland-Jones C, Lin H, Shen Y, Bedrosian I, Shaitelman S, Kuerer H, Woodward WA, Ueno N, Valero V, Babiera G. Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys 95(4):1218-25, 2016. e-Pub 2016. PMID: 27209502.
142. Wolfe AR, Bambhroliya A, Reddy JP, Debeb BG, Huo L, Larson R, Li L, Ueno NT, Woodward WA. MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer. Int J Radiat Oncol Biol Phys 95(2):791-9, 2016. e-Pub 2016. PMID: 27055396.
143. Ovalle V, Strom EA, Godby J, Shaitelman SF, Stauder MC, Amos RA, Kuerer HM, Woodward WA, Hoffman KE. Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly?. Int J Radiat Oncol Biol Phys 95(1):49-51, 2016. e-Pub 2016. PMID: 27084625.
144. Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Wu W, Calin GA, Krishnamurthy S, Zhang XH, Buchholz TA, Ueno NT, Reuben JM, Woodward WA. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst 108(8), 2016. e-Pub 2016. PMID: 27075851.
145. Debeb BG, Lacerda L, Larson R, Wolfe AR, Krishnamurthy S, Reuben JM, Ueno NT, Gilcrease M, Woodward WA. Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism. Oncotarget. e-Pub 2016. PMID: 27078845.
146. Pan HY, Shaitelman SF, Perkins GH, Schlembach PJ, Woodward WA, Smith BD. Implementing a Real-Time Electronic Data Capture System to Improve Clinical Documentation in Radiation Oncology. J Am Coll Radiol 13(4):401-407, 2016. e-Pub 2016. PMID: 26681164.
147. Atkinson RL, El-Zein R, Valero V, Lucci A, Bevers TB, Fouad T, Liao W, Ueno NT, Woodward WA, Brewster AM. Epidemiological risk factors associated with inflammatory breast cancer subtypes. Cancer Causes Control 27(3):359-366, 2016. e-Pub 2016. PMID: 26797453.
148. Rahal, O, Woodward, W. Cholesterol and Radiosensitivity. Current Breast Cancer Reports 8(1):32-39, 2016. e-Pub 2016.
149. Ilmer M, Mazurek N, Gilcrease MZ, Byrd JC, Woodward WA, Buchholz TA, Acklin K, Ramirez K, Hafley M, Alt E, Vykoukal J, Bresalier RS. Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells. Breast Cancer Res 18(1):97, 2016. e-Pub 2016. PMID: 27687248.
150. Mego M, Gao H, Cohen EN, Anfossi S, Giordano A, Sanda T, Fouad TM, De Giorgi U, Giuliano M, Woodward WA, Alvarez RH, Valero V, Ueno NT, Hortobagyi GN, Cristofanilli M, Reuben JM. Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer. J Cancer 7(9):1095-104, 2016. e-Pub 2016. PMID: 27326253.
151. Caceres S, Peña L, Silvan G, Illera MJ, Woodward WA, Reuben JM, Illera JC. Steroid Tumor Environment in Male and Female Mice Model of Canine and Human Inflammatory Breast Cancer. Biomed Res Int 2016:8909878, 2016. e-Pub 2016. PMID: 27195300.
152. Wolfe AR, Debeb BG, Lacerda L, Larson R, Bambhroliya A, Huang X, Bertucci F, Finetti P, Birnbaum D, Van Laere S, Diagaradjan P, Ruffell B, Trenton NJ, Chu K, Hittelman W, Diehl M, Levental I, Ueno NT, Woodward WA. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a. Breast Cancer Res Treat 154(3):495-508, 2015. e-Pub 2015. PMID: 26590814.
153. Illera JC, Caceres S, Peña L, de Andres PJ, Monsalve B, Illera MJ, Woodward WA. Steroid hormone secretion in inflammatory breast cancer cell lines. Horm Mol Biol Clin Investig 24(3):137-145, 2015. e-Pub 2015. PMID: 26495931.
154. Bishop AJ, Ensor J, Moulder SL, Shaitelman SF, Edson MA, Whitman GJ, Bishnoi S, Hoffman KE, Stauder MC, Valero V, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy. Cancer 121(24):4324-4332, 2015. e-Pub 2015. PMID: 26348887.
155. Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol 1(7):931-41, 2015. e-Pub 2015. PMID: 26247543.
156. Reddy JP, Dawood S, Mitchell M, Debeb BG, Bloom E, Gonzalez-Angulo AM, Sulman EP, Buchholz TA, Woodward WA. Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. Radiother Oncol. e-Pub 2015. PMID: 26482599.
157. Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ. Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys 93(1):102-10, 2015. e-Pub 2015. PMID: 26279028.
158. Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT. Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Res Treat 152(2):417, 2015. e-Pub 2015. PMID: 26092296.
159. Strom EA, Amos RA, Shaitelman SF, Kerr MD, Hoffman KE, Smith BD, Tereffe W, Stauder MC, Perkins GH, Amin MD, Wang X, Poenisch F, Ovalle V, Buchholz TA, Babiera G, Woodward WA. Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique. Pract Radiat Oncol 5(4):e283-90, 2015. e-Pub 2015. PMID: 25804105.
160. Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Res Treat 152(2):407-16, 2015. e-Pub 2015. PMID: 26017070.
161. Holliday EB, Ahmed AA, Jagsi R, Stentz NC, Woodward WA, Fuller CD, Thomas CR. Pregnancy and Parenthood in Radiation Oncology, Views and Experiences Survey (PROVES): Results of a Blinded Prospective Trainee Parenting and Career Development Assessment. Int J Radiat Oncol Biol Phys 92(3):516-24, 2015. e-Pub 2015. PMID: 25892584.
162. Tsai CJ, Li J, Gonzalez-Angulo AM, Allen PK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Yang W, Cristofanilli M, Valero V, Buchholz TA. Outcomes after multidisciplinary treatment of inflammatory breast cancer in the era of neoadjuvant HER2-directed therapy. Am J Clin Oncol 38(3):242-7, 2015. e-Pub 2015. PMID: 23648437.
163. Wolfe AR, Atkinson RL, Reddy JP, Debeb BG, Larson R, Li L, Masuda H, Brewer T, Atkinson BJ, Brewster A, Ueno NT, Woodward WA. High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer. Int J Radiat Oncol Biol Phys 91(5):1072-1080, 2015. e-Pub 2015. PMID: 25832697.
164. Parinyanitikul, N, Lei, X, Chavez Mac Gregor, M, Liu, S, Mittendorf, EA, Litton, J, Woodward, W, Zhang, H, Hortobagyi, GN, Valero, V, Meric-Bernstam, F, González-Angulo, AM. Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes. Clinical breast cancer 15(2):153-160, 2015. e-Pub 2015. PMID: 25454687.
165. Stauder, MC, Woodward, W. Local-regional treatment of the patient with inflammatory breast cancer. Current Breast Cancer Reports 7(1):37-42, 2015. e-Pub 2015.
166. Debeb BG, Smith DL, Li L, Larson R, Xu W, Woodward WA. Differential effect of phosphorylation-defective surviving on radiation response in estrogen receptor-positive and -negative breast cancer. PLoS One 10(3):e0120719. e-Pub 2015. PMID: 25763854.
167. Mego M, Zuo Z, Gao H, Cohen EN, Giordano A, Tin S, Anfossi S, Jackson S, Woodward WA, Ueno NT, Valero V, Alvarez RH, Hortobagyi GN, Khoury JD, Cristofanilli M, Reuben JM. Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer. Thromb Haemost 113(2):593-8, 2015. e-Pub 2015. PMID: 25373787.
168. Mego M, Giordano A, De Giorgi U, Masuda H, Hsu L, Giuliano M, Fouad TM, Dawood S, Ueno NT, Valero V, Andreopoulou E, Alvarez RH, Woodward WA, Hortobagyi GN, Cristofanilli M, Reuben JM. Circulating tumor cells in newly diagnosed inflammatory breast cancer. Breast Cancer Res 17(1):2, 2015. e-Pub 2015. PMID: 25572591.
169. Cohen EN, Gao H, Anfossi S, Mego M, Reddy NG, Debeb B, Giordano A, Tin S, Wu Q, Garza RJ, Cristofanilli M, Mani SA, Croix DA, Ueno NT, Woodward WA, Luthra R, Krishnamurthy S, Reuben JM. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells. PLoS One 10(7):e0132710, 2015. e-Pub 2015. PMID: 26207636.
170. Thaker NG, Hoffman KE, Stauder MC, Shaitelman SF, Strom EA, Tereffe W, Smith BD, Perkins GH, Huo L, Munsell MF, Pusztai L, Buchholz TA, Woodward WA. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. Springerplus 4:36, 2015. e-Pub 2015. PMID: 25674496.
171. Putcha P, Yu J, Rodriguez-Barrueco R, Saucedo-Cuevas L, Villagrasa P, Murga-Penas E, Quayle SN, Yang M, Castro V, Llobet-Navas D, Birnbaum D, Finetti P, Woodward WA, Bertucci F, Alpaugh ML, Califano A, Silva J. HDAC6 Activity is a Non-Oncogene Addiction Hub for Inflammatory Breast Cancers. Breast Cancer Res 17(1):149, 2015. e-Pub 2015. PMID: 26643555.
172. Zhang Y, Nowicka A, Solley TN, Wei C, Parikh A, Court L, Burks JK, Andreeff M, Woodward WA, Dadbin A, Kolonin MG, Lu KH, Klopp AH. Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers. PLoS One 10(8):e0136361, 2015. e-Pub 2015. PMID: 26317219.
173. Caceres S, Peña L, de Andres PJ, Illera MJ, Lopez MS, Woodward WA, Reuben JM, Illera JC. Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366. PLoS One 10(3):e0122277, 2015. e-Pub 2015. PMID: 25807360.
174. Lacerda L, Debeb BG, Smith D, Larson R, Solley T, Xu W, Krishnamurthy S, Gong Y, Levy LB, Buchholz T, Ueno NT, Klopp A, Woodward WA. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model. Breast Cancer Res 17(1):42, 2015. e-Pub 2015. PMID: 25887413.
175. Shaitelman SF, Buchholz TA, Hunt KK, Hortobagyi GN, Schlembach P, Arzu I, Bloom E, Chronowski G, Dvorak T, Grade E, Hoffman KE, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Smith BD. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at six months compared to conventionally fractionated whole breast irradiation: results of a randomized Trial. Int J Radiat Oncol Biol Phys 90(5):1264, 2014. e-Pub 2014. PMID: 25539386.
176. Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, Yuan J, Wang M, Chen D, Sun Y, Woodward WA, Liu Y, Dean DC, Liang H, Hu Y, Ang KK, Hung MC, Chen J, Ma L. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol 16(9):864-75, 2014. e-Pub 2014. PMID: 25086746.
177. Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KK. Implementation of the American College of Surgeons Oncology Group Z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?. Ann Surg Oncol 21(8):2468-73, 2014. e-Pub 2014. PMID: 24841348.
178. Lacerda L, Reddy JP, Liu D, Larson R, Li L, Masuda H, Brewer T, Debeb BG, Xu W, Hortobágyi GN, Buchholz TA, Ueno NT, Woodward WA. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation. Stem Cells Transl Med 3(7):849-56, 2014. e-Pub 2014. PMID: 24833589.
179. Debeb BG, Gong Y, Atkinson RL, Sneige N, Huo L, Gonzalez-Angulo A, Hung MC, Valero V, Ueno NT, Woodward WA. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. J Exp Clin Cancer Res 33(1):58. e-Pub 2014. PMID: 25051981.
180. McBride A, Allen P, Woodward WA, Kim M, Kuerer HM, Drinka EK, Sahin A, Strom EA, Buzdar A, Valero V, Hortobagyi GN, Hunt KK, Buchholz TA. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys 89(2):392-398, 2014. e-Pub 2014. PMID: 24721590.
181. Gong Y, Wang J, Huo L, Wei W, Ueno NT, Woodward WA. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining. Clin Breast Cancer 14(3):e81-8, 2014. e-Pub 2014. PMID: 24461456.
182. Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt KK, Huo L, Babiera GV. Primary tumor resection as a component of multimodality treatment may improve local control and survival in stage IV inflammatory breast cancer. Cancer 120(9):1319-28, 2014. e-Pub 2014. PMID: 24510381.
183. Yang J, Woodward WA, Reed VK, Strom EA, Perkins GH, Tereffe W, Buchholz TA, Zhang L, Balter P, Court LE, Li XA, Dong L. Statistical modeling approach to quantitative analysis on inter-observer variability in breast contouring. Int J Radiat Oncol Biol Phys 89(1):214-221, 2014. e-Pub 2014. PMID: 24613812.
184. Shaitelman SF, Khan AJ, Woodward WA, Arthur DW, Cuttino LW, Bloom ES, Shah C, Freedman GM, Wilkinson JB, Babiera GV, Julian TB, Vicini FA. Shortened radiation therapy schedules for early-stage breast cancer: A review of hypofractionated whole-breast irradiation and accelerated partial breast irradiation. Breast J 20(2):131-46, 2014. e-Pub 2014. PMID: 24479632.
185. MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE. Therapeutic radiation dose delivered to the low axilla during whole breast radiotherapy in the prone position: implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116-122, 2014. e-Pub 2014. PMID: 24890352.
186. Bertucci F, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, Van Dam P, Woodward WA, Cristofanilli M, Reuben JM, Dirix L, Viens P, Symmans WF, Birnbaum D, Van Laere SJ. Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival. Ann Oncol 25(2):358-65, 2014. e-Pub 2014. PMID: 24299959.
187. Masuda H, Brewer TM, Liu DD, Iwamoto T, Shen Y, Hsu L, Willey JS, Gonzalez-Angulo AM, Chavez-MacGregor M, Fouad TM, Woodward WA, Reuben JM, Valero V, Alvarez RH, Hortobagyi GN, Ueno NT. Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes. Ann Oncol 25(2):384-91, 2014. e-Pub 2014. PMID: 24351399.
188. Woodward WA, Krishnamurthy S, Lodhi A, Xiao L, Gong Y, Cristofanilli M, Buchholz TA, Lucci A. Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells. J Cancer 5(5):360-367, 2014. e-Pub 2014. PMID: 24799954.
189. Anfossi S, Giordano A, Gao H, Cohen EN, Tin S, Wu Q, Garza RJ, Debeb BG, Alvarez RH, Valero V, Hortobagyi GN, Calin GA, Ueno NT, Woodward WA, Reuben JM. High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2(+) inflammatory breast cancer. PLoS One 9(1):e83113, 2014. e-Pub 2014. PMID: 24416156.
190. Zhang P, Wang L, Rodriguez-Aguayo C, Yuan Y, Debeb BG, Chen D, Sun Y, You MJ, Liu Y, Dean DC, Woodward WA, Liang H, Yang X, Lopez-Berestein G, Sood AK, Hu Y, Ang KK, Chen J, Ma L. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat Commun 5:5671, 2014. e-Pub 2014. PMID: 25476932.
191. Smith D, Kong F, Yang D, Larson R, Sims-Mourtada J, Woodward WA. Patched targeted peptides for imaging and treatment of hedgehog positive breast tumors. Biomed Res Int 2014:525680, 2014. e-Pub 2014. PMID: 25276795.
192. Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez RH, Hoffman KE, Perkins GH, Strom EA, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. Springerplus 3:166, 2014. e-Pub 2014. PMID: 24711988.
193. Woodward WA, Koay E, Takiar V. Radiation therapy for inflammatory breast cancer: technical considerations and diverse clinical scenarios. Breast Cancer Manage 3(1):43-52, 2014. e-Pub 2014.
194. Haricharan S, Dong J, Hein S, Reddy JP, Du Z, Toneff M, Holloway KR, Hilsenbeck S, Huang S, Atkinson RL, Woodward WA, Jindal S, Borges V, Gutierrez C, Zhang H, Schedin P, Osborne CK, Tweardy DJ, Li Y. Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy. eLife. e-Pub 2013. PMID: 24381245.
195. Masuda H, Baggerly KA, Wang Y, Iwamoto T, Brewer T, Pusztai L, Kai K, Kogawa T, Finetti P, Birnbaum D, Dirix L, Woodward WA, Reuben JM, Krishnamurthy S, Symmans WF, Van Laere SJ, Bertucci F, Hortobagyi GN, Ueno NT. Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers. Breast Cancer Res 15(6):R112. e-Pub 2013. PMID: 24274653.
196. Wang X, Saso H, Iwamoto T, Xia W, Gong Y, Pusztai L, Woodward WA, Reuben JM, Warner SL, Bearss DJ, Hortobagyi GN, Hung MC, Ueno NT. TIG1 promotes the development and progression of inflammatory breast cancer through activation of Ax1 Kinase. Cancer Res 73(21):6516-25, 2013. e-Pub 2013. PMID: 24014597.
197. Giordano A, Gao H, Cohen EN, Anfossi S, Khoury J, Hess K, Krishnamurthy S, Tin S, Cristofanilli M, Hortobagyi GN, Woodward WA, Lucci A, Reuben JM. Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients. Ann Oncol 24(10):2515-21, 2013. e-Pub 2013. PMID: 23798614.
198. Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA. Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?. Br J Radiol 86(1029):20130176, 2013. e-Pub 2013. PMID: 23728947.
199. Van Laere SJ, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, van Dam P, Woodward WA, Viens P, Cristofanilli M, Birnbaum D, Dirix L, Reuben JM, Bertucci F. Uncovering the molecular secrets of inflammatory breast cancer biology: An integrated analysis of three distinct affymetrix gene expression data sets. Clin Cancer Res 19(17):4685-4696, 2013. e-Pub 2013. PMID: 23396049.
200. Atkinson RL, Yang WT, Rosen DG, Landis MD, Wong H, Lewis MT, Creighton CJ, Sexton KR, Hilsenbeck SG, Sahin AA, Brewster AM, Woodward WA, Chang JC. Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency. Breast Cancer Res 15(5):R77. e-Pub 2013. PMID: 24008095.
201. Kim MM, Allen P, Gonzalez-Angulo AM, Woodward WA, Meric-Bernstam F, Buzdar AU, Hunt KK, Kuerer HM, Litton JK, Hortobagyi GN, Buchholz TA, Mittendorf EA. Pathologic complete response to neoadjuvant chemotherapy with Trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer. Ann Oncol 24(8):1999-2004, 2013. e-Pub 2013. PMID: 23562929.
202. Xu W, Lacerda L, Debeb BG, Atkinson RL, Solley T, Li L, Orton D, McMurray JS, Hang BI, Lee E, Klopp A, Ueno NT, Reuben JM, Krishnamurthy S, Woodward WA. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer. PLoS One 8(e71508), 2013. e-Pub 2013. PMID: 24013655.
203. Brewer TM, Masuda H, Liu DD, Shen Y, Liu P, Iwamoto T, Kai K, Barnett CM, Woodward WA, Reuben JM, Yang P, Hortobagyi GN, Ueno NT. Statin use in primary inflammatory breast cancer: a cohort study. Br J Cancer. e-Pub 2013. PMID: 23820253.
204. Woodward WA, Krishnamurthy S, Yamauchi H, El-Zein R, Ogura D, Kitadai E, Niwa S, Cristofanilli M, Vermeulen P, Dirix L, Viens P, van Laere S, Bertucci F, Reuben JM, Ueno NT. Genomic and expression analysis of microdissected inflammatory breast cancer. Breast Cancer Res Treat 138(3):761-72, 2013. e-Pub 2013. PMID: 23568481.
205. Nowicka A, Marini FC, Solley TN, Elizondo PB, Zhang Y, Sharp HJ, Broaddus R, Kolonin M, Mok SC, Thompson MS, Woodward WA, Lu K, Salimian B, Nagrath D, Klopp AH. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PLoS One 8(12):e81859, 2013. e-Pub 2013. PMID: 24312594.
206. Skinner HD, Strom EA, Motwani SB, Woodward WA, Green MC, Babiera G, Booser DJ, Meric-Bernstam F, Buchholz TA. Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy. Radiat Oncol 8(1):13, 2013. e-Pub 2013. PMID: 23311297.
207. FitzSullivan, E, Lari, SA, Smith, B, Caudle, AS, Krishnamurthy, S, Lucci, A, Mittendorf, EA, Babiera, G, Black, DM, Wagner, JL, Bedrosian, I, Woodward, W, DeSnyder, SM, Hwang, RF, Meric-Bernstam, F, Hunt, KK, Kuerer, HM. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy. Annals of surgical oncology 20(13):4103-4112, 2013. e-Pub 2013. PMID: 23975313.
208. Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R, Sulman EP, Ueno NT, Krishnamurthy S, Reuben JM, Buchholz TA, Woodward WA. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/B-catenin signaling. Stem Cells 30(11):2366-2377, 2012. e-Pub 2012. PMID: 22961641.
209. Kim MM, Dawood S, Allen P, Sahin AA, Woodward WA, Smith BD, Strom EA, Hunt KK, Meric-Bernstam F, Gonzalez-Angulo AM, Buchholz TA. Hormone receptor status influences the locoregional benefit of Trastuzumab in patients with non-metastatic breast cancer. Cancer 118(20):4936-43, 2012. e-Pub 2012. PMID: 22511276.
210. Iyengar P, Strom EA, Zhang YJ, Whitman GJ, Smith BD, Woodward WA, Yu TK, Buchholz TA. The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer. Oncologist 17(11):1402-1408, 2012. e-Pub 2012. PMID: 22982581.
211. Walker GV, Niikura N, Yang W, Rohren E, Valero V, Woodward WA, Alvarez RH, Lucci A, Ueno NT, Buchholz TA. Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs. Int J Radiat Oncol Biol Phys 83(5):1381-6, 2012. e-Pub 2012. PMID: 22284689.
212. Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward WA, Oh JL, Arriaga L, Munsell MF, Kelly P, Hoffman KE, Smith BD, Buchholz TA, Yu TK. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys 83(4):1089-94, 2012. e-Pub 2012. PMID: 22172912.
213. BG* D, EN* C, Boley K, Freiter EM, Li L, Robertson FM, Reuben JM, Cristofanilli M, Buchholz TA, (*co-first authors) WW. Pre-clinical studies of notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Res Treat 134(2):495-510, 2012. e-Pub 2012. PMID: 22547109.
214. Fontanilla HP, Woodward WA, Lindberg ME, Kanke JE, Arora G, Durbin RR, Yu TK, Zhang L, Sharp HJ, Strom EA, Salehpour M, White J, Buchholz TA, Dong L. Current clinical coverage of Radiation Therapy Oncology Group-defined target volumes for postmastectomy radiation therapy. Pract Radiat Oncol 2(3):201-209, 2012. e-Pub 2012. PMID: 24674124.
215. Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, Cristofanilli M. Identifying factors that impact survival among women with inflammatory breast cancer. Ann Oncol 23(4):870-5, 2012. e-Pub 2012. PMID: 21765048.
216. Klopp AH, Zhang Y, Solley T, Amaya-Manzanares F, Marini F, Andreeff M, Debeb B, Woodward WA, Schmandt R, Broaddus R, Lu K, Kolonin MG. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res 18(3):771-82, 2012. e-Pub 2012. PMID: 22167410.
217. Wang X, Pan T, Pinnix C, Zhang SX, Salehpour M, Sun TL, Gladish G, Strom EA, Perkins GH, Tereffe W, Woodward WA, Hoffman KE, Buchholz TA, Yu TK. Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 82(2):708-14, 2012. e-Pub 2012. PMID: 21444161.
218. Amos RA, Woodward WA. Field match verification during combination proton, photon and electron therapy for oligometastatic inflammatory breast cancer. Med Dosim 37(4):442-4, 2012. e-Pub 2012. PMID: 22609618.
219. Sims-Mourtada J, Yang D, Tworowska I, Larson R, Smith D, Tsao N, Opdenaker L, Mourtada F, Woodward WA. Detection of Canonical Hedgehog Signaling in Breast Cancer by 131 iodine labeled derivatives of the Sonic Hedgehog protein. J Biomed Biotechnol 2012:639562, 2012. e-Pub 2012. PMID: 22811598.
220. Nagar H, Mittendorf EA, Strom EA, Perkins GH, Oh JL, Tereffe W, Woodward WA, Gonzalez-Angulo AM, Hunt KK, Buchholz TA, Yu TK. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically-staged T3N0 breast cancer. Int J Radiat Oncol Biol Phys 81(3):782-7, 2011. e-Pub 2011. PMID: 21885207.
221. Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, Wagner J, Hunt KK, Woodward WA, Meric-Bernstam F. Triple-negative breast cancer is not a contraindication for breast conservation. Ann Surg Oncol 18(11):1364-1373, 2011. e-Pub 2011. PMID: 21947595.
222. Theriault RL, Litton JK, Mittendorf EA, Chen H, Meric-Bernstam F, Chavez-Macgregor M, Morrow PK, Woodward WA, Sahin A, Hortobagyi GN, Gonzalez-Angulo AM. Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype. Clin Breast Cancer 11(5):325-331, 2011. e-Pub 2011. PMID: 21764391.
223. Lang JY, Hsu JL, Meric-Bernstam F, Chang CJ, Wang Q, Bao Y, Yamaguchi H, Xie X, Woodward WA, Yu D, Hortobagyi GN, Hung MC. BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment. Cancer Cell 20(3):341-356, 2011. e-Pub 2011. PMID: 21907925.
224. Woodward WA, H* G, E* C, Li L, Xu W, Debeb BG, Jimenez CA, Krishnamurthy S, Tucker SL, Hortobagyi GN, Cristofanilli M, Buchholz TA, (*co-second authors) RJ. Percentage of CD45-CD326+ CD44+CD24-/lo cells in pleural effusion fluid of patients with metastatic breast cancer predicts for overall survival. Interventional Oncology 1(1):4-10, 2011. e-Pub 2011.
225. Wang X, Amos RA, Zhang X, Taddei PJ, WA* W, Hoffman KE, Yu TK, Tereffe W, Oh J, Perkins GH, Salehpour M, Zhang SX, Sun TL, Gillin M, Buchholz TA, (*corresponding author) SE. External-Beam Accelerated Partial Breast Irradiation Using Multiple Proton Beam Configurations. Int J Radiat Oncol Biol Phys 80(5):1464-72, 2011. e-Pub 2011. PMID: 20708848.
226. Reddy JP, Levy L, Oh JL, Strom EA, Perkins GH, Buchholz TA, Woodward WA. Long-Term Outcomes in Patients with Isolated Supraclavicular Nodal Recurrence After Mastectomy and Doxorubicin-Based Chemotherapy for Breast Cancer. Int J Radiat Oncol Biol Phys 80(5):1453-7, 2011. e-Pub 2011. PMID: 21168284.
227. Albert JM, Buzdar AU, Guzman R, Allen PK, Strom EA, Perkins GH, Woodward WA, Hoffman KE, Tereffe W, Hunt KK, Buchholz TA, Oh JL. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Treat 128(2):421-7, 2011. e-Pub 2011. PMID: 21553292.
228. Reuben JM, Lee BN, Gao H, Cohen EN, Mego M, Giordano A, Wang X, Lodhi A, Krishnamurthy S, Hortobagyi GN, Cristofanilli M, Lucci A, Woodward WA. Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+CD24lo cancer stem cell phenotype. Eur J Cancer 47(10):1527-36, 2011. e-Pub 2011. PMID: 21334874.
229. Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, Cristofanilli M. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study. Cancer 117(9):1819-26, 2011. e-Pub 2011. PMID: 21509759.
230. Xu W, Debeb BG, Lacerda L, Li J, Woodward WA. Tetrandrine, a compound common in Chinese traditional medicine, preferentially kills breast cancer tumor initiating cells (TICs) in vitro. Cancers 3(2):2274-2285, 2011. e-Pub 2011. PMID: 24212809.
231. Fontanilla HP, Woodward WA, Lindberg ME, Zhang L, Sharp HJ, Strom EA, Salehpour M, Buchholz TA, Dong L. Automating RTOG-defined target volumes for postmastectomy radiation. Practical Radiation Oncology 1(2):97-104. e-Pub 2011. PMID: 24673923.
232. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TA. Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer. Cancer 117(8):1595-601, 2011. e-Pub 2011. PMID: 21472707.
233. Dawood S, Merajver SD, Vients P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22(3):515-523, 2011. e-Pub 2011. PMID: 20603440.
234. Suarez J, Arthur D, Woodward WA, Kuerer HM. Breast preservation in patients with local recurrence after breast-conserving therapy. Curr Breast Cancer Rep. e-Pub 2011.
235. Iwamoto T, Bianchini G, Qi Y, Cristofanilli M, Lucci A, Woodward WA, Reuben JM, Matsuoka J, Gong Y, Krishnamurthy S, Valero V, Hortobagyi GN, Robertson F, Symmans WF, Pusztai L, Ueno NT. Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer. Breast Cancer Res Treat 125(3):785-95, 2011. e-Pub 2011. PMID: 21153052.
236. Beadle BM, Woodward WA, Buchholz TA. The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol 21(1):26-34, 2011. e-Pub 2011. PMID: 21134651.
237. Li J, Gonzalez-Angulo AM, Allen PK, Yu TK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Bondy ML, Yang W, Willey JS, Cristofanilli M, Valero V, Buchholz TA. Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer. Oncologist 16(12):1675-83, 2011. e-Pub 2011. PMID: 22147002.
238. Chang CJ, Yang JY, Xia W, Chen CT, Xie X, Chao CH, Woodward WA, Hsu JM, Hortobagyi GN, Hung MC. EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-ß-Catenin Signaling. Cancer Cell 19(1):86-100, 2011. e-Pub 2011. PMID: 21215703.
239. Dawood S, Ueno NT, Valero V, Andreopoulou E, Hsu L, Lara J, Woodward WA, Buchholz TA, Hortobagyi GN, Cristofanilli M. Incidence of and survival following brain metastases among women with inflammatory breast cancer. Ann Oncol 21(12):2348-55, 2010. e-Pub 2010. PMID: 20439340.
240. Atkinson RL, Zhang M, Diagaradjane P, Peddibhotla S, Contreras A, Hilsenbeck SG, Woodward WA, Krishnan S, Chang JC, Rosen JM. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med 2(55):55ra79, 2010. e-Pub 2010. PMID: 20980696.
241. Woodward WA, Truong PT, Yu TK, Tereffe W, Oh J, Perkins G, Strom E, Meric-Bernstam F, Gonzalez-Angulo AM, Speers C, Ragaz J, Buchholz TA. Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival. Breast Cancer Res Treat 123(2):597-605, 2010. e-Pub 2010. PMID: 20306128.
242. Walker GV, Smith GL, Perkins GH, Oh JL, Woodward WA, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer 116(17):4000-6, 2010. e-Pub 2010. PMID: 20564117.
243. Robertson FM, Ogasawara MA, Ye Z, Chu K, Pickei R, Debeb BG, Woodward WA, Hittelman WN, Cristofanilli M, Barsky SH. Imaging and analysis of tumor cells within 3 dimensional tumor spheroids that are enriched for a cancer stem cell phenotype. J Biomol Screen 15(7):820-9, 2010. e-Pub 2010. PMID: 20639504.
244. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, Woodward WA, Tucker SL, Hunt KK, Hortobagyi GN, Buchholz TA. Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys 77(5):1296-1302, 2010. e-Pub 2010. PMID: 20472353.
245. Dawood S, Gonzalez-Angulo AM, Albarracin C, Yu TK, Hortobagyi GN, Buchholz TA, Woodward WA. Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy: a single-institution review. Cancer 116(13):3084-92, 2010. e-Pub 2010. PMID: 20564633.
246. Dawood S, Gong Y, Xia W, Broglio K, Yang W, Le-Petross CH, Buchholz TA, Woodward WA, Lucci A, Valero V, Gonzalez-Angulo AM, Andreopoulou E, Hortobagyi GN, Cristofanilli M. Trastuzumab in primary inflammatory breast cancer (IBC): high pathological response rates and favorable outcome. Breast J. e-Pub 2010. PMID: 20626396.
247. Zhang YJ, Oh JL, Whitman GJ, Iyengar P, Yu TK, Tereffe W, Woodward WA, Perkins G, Buchholz TA, Strom EA. Clinically Apparent Internal Mammary Nodal Metastasis in Patients with Advanced Breast Cancer: Incidence and Local Control. Int J Radiat Oncol Biol Phys 77(4):1113-9, 2010. e-Pub 2010. PMID: 20004535.
248. Robertson FM, Woodward WA, Pickei R, Ye Z, Bornmann W, Pal A, Peng Z, Hall CS, Cristofanilli M. Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids. Cancer 116(11 Suppl):2760-7, 2010. e-Pub 2010. PMID: 20503408.
249. Greenbaum MP, Strom EA, Allen PK, Perkins GH, Oh JL, Tereffe W, Yu TK, Buchholz TA, Woodward WA. Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy, modified radical mastectomy, and post-mastectomy radiation. Radiother Oncol 95(3):312-6, 2010. e-Pub 2010. PMID: 20227126.
250. Debeb BG, Xu W, Mok H, Li L, Robertson F, Ueno NT, Reuben J, Lucci A, Cristofanilli M, Woodward WA. Differential radiosensitizing effect of valproic acid in differentiation versus self renewal promoting culture conditions. Int J Radiat Oncol Biol Phys 76(3):889-895, 2010. e-Pub 2010. PMID: 20159363.
251. Smith GL, Shih YC, Xu Y, Giordano SH, Smith BD, Perkins GH, Tereffe W, Woodward WA, Buchholz TA. Racial disparities in the use of radiotherapy after breast-conserving surgery: A national Medicare study. Cancer 116(3):734-41, 2010. e-Pub 2010. PMID: 20014181.
252. AH* K, L* L, Gupta A, Debeb BG, Solley T, Li L, Spaeth E, Xu W, Zhang X, Lewis MT, Reuben JM, Krishnamurthy S, Ferrari M, Gaspar R, Buchholz TA, Cristofanilli M, Marini F, Andreeff M, (*co-first authors) WW. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 5(8), 2010. e-Pub 2010. PMID: 20808935.
253. Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT, Robertson F, Xu W, Lacerda L, Buchholz TA, Cristofanilli M, Reuben JM, Lewis MT, Woodward WA. Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol Cancer 9(1):180, 2010. e-Pub 2010. PMID: 20615238.
254. Liedtke C, Broglio K, Moulder S, Hsu L, Kau SW, Symmans WF, Albarracin C, Meric-Bernstam F, Woodward WA, Theriault RL, Kiesel L, Hortobagyi GN, Pusztai L, Gonzalez-Angulo AM. Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. Ann Oncol 20(12):1953-8, 2009. e-Pub 2009. PMID: 19596702.
255. Gilcrease MZ, Zhou X, Lu X, Woodward WA, Hall BE, Morrissey PJ. Alpha6beta4 integrin crosslinking induces EGFR clustering and promotes EGF-mediated Rho activation in breast cancer. Journal of Experimental and Clinical Cancer Research 28(67), 2009. e-Pub 2009. PMID: 19470173.
256. Gilcrease MZ, Woodward WA, Nicolas MM, Corley LJ, Fuller GN, Esteva FJ, Tucker SL, Buchholz TA. Even Low-level HER2 Expression May be Associated With Worse Outcome in Node-positive Breast Cancer. Am J Surg Pathol 33(5):759-67, 2009. e-Pub 2009. PMID: 19252432.
257. Reed VK, Woodward WA, Zhang L, Strom EA, Perkins GH, Tereffe W, Oh JL, Yu TK, Bedrosian I, Whitman GJ, Buchholz TA, Dong L. Automatic Segmentation of Whole Breast Using Atlas Approach and Deformable Image Registration. Int J Radiat Oncol Biol Phys 73(5):1493-500, 2009. e-Pub 2009. PMID: 18804333.
258. Vinh-Hung V, Truong PT, Janni W, Nguyen NP, Vlastos G, Cserni G, Royce ME, Woodward WA, Promish D, Tai P, Soete G, Balmer-Majno S, Cutuli B, Storme G, Bouchardy C. The effect of adjuvant radiotherapy on mortality differs according to primary tumor location in women with node-positive breast cancer. Strahlenther Onkol 185(3):161-168, 2009. e-Pub 2009. PMID: 19330292.
259. Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH. The impact of pregnancy on breast cancer outcomes in women </=35 years. Cancer 115(6):1174-84, 2009. e-Pub 2009. PMID: 19204903.
260. Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu TK, Meric-Bernstam F, Litton JK, Buchholz TA. Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment Approach. Int J Radiat Oncol Biol Phys 73(3):734-44, 2009. e-Pub 2009. PMID: 18707822.
261. Li XA, Tai A, Arthur DW, Buchholz TA, MacDonald S, Marks LB, Moran JM, Pierce LJ, Rabinovitch R, Taghian A, Vicini F, Woodward WA, White JR. Variability of target and normal structure delineation for breast-cancer radiotherapy: a RTOG multi-institutional and multi-observer study. Int J Radiat Oncol Biol Phys 73(3):944-951, 2009. e-Pub 2009. PMID: 19215827.
262. Debeb BG, Galat V, Epple-Farmer J, Iannaccone S, Woodward WA, Bader M, Iannaccone P, Binas B. Isolation of Oct4-expressing extraembryonic endoderm precursor cell lines. PLoS One 4(9):e7216, 2009. e-Pub 2009. PMID: 19784378.
263. Gilcrease MZ, Kilpatrick SK, Woodward WA, Zhou X, Nicolas MM, Corley LJ, Fuller GN, Tucker SL, Diaz LK, Buchholz TA, Frost JA. Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis. Caner Epidemiol Biomarkers 18(1):80-86, 2009. e-Pub 2009. PMID: 19124484.
264. Truong PT, Vinh-Hung V, Cserni G, Woodward WA, Tai P, Vlastos G, Vlastos G. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer 44(12):1670-1677, 2008. e-Pub 2008. PMID: 18595686.
265. Smith GL, Smith BD, Buchholz TA, Giordano SH, Garden AS, Woodward WA, Krumholz HM, Weber RS, Ang KK, Rosenthal DI. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol 26(31):5119-25, 2008. e-Pub 2008. PMID: 18725647.
266. Garg AK, Frija EK, Sun TL, Strom EA, Perkins GH, Oh JL, Yu TK, Woodward WA, Tereffe WA, Salehpour M, Buchholz TA. Effects of Variable Placement of Superior Tangential/Supraclavicular Match Line on Dosimetric Coverage of Level III Axilla/Axillary Apex in Patients Treated with Breast and Supraclavicular Radiotherapy. Int J Radiat Oncol Biol Phys 73(2):370-4, 2008. e-Pub 2008. PMID: 18676090.
267. Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and 1-3 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 2008. e-Pub 2008. PMID: 18234447.
268. Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Locoregional Treatment Outcomes After Multimodality Management Of Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys 72(2):474-84, 2008. e-Pub 2008. PMID: 18439768.
269. Smith GL, Smith BD, Giordano SH, Shih YT, Woodward WA, Strom EA, Perkins GH, Tereffe W, Yu TK, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112(6):1371-1379, 2008. e-Pub 2008. PMID: 18213620.
270. Reed VK, Cavalcanti JL, Strom EA, Perkins GH, Oh JL, Tereffe W, Yu TK, Yeung H, Whitman GJ, Bedrosian I, Macapinlac HA, Buchholz TA, Woodward WA. Risk of subclinical micrometastatic disease in the supraclavicular nodal bed based on the anatomical distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys 71(2):435-40, 2007. e-Pub 2007. PMID: 18164831.
271. Woodward WA, Durand JB, Tucker SL, Strom EA, Perkins GH, Oh JL, Arriaga L, Domain D, Buchholz TA. Prospective analysis of carotid flow in breast cancer patients treated with supraclavicular irradiation eight or more years prior to study: No increase in ipsilateral carotid stenosis after radiation. Cancer 112(2):268-273, 2007. e-Pub 2007. PMID: 18000801.
272. Klopp AH, Spaeth EL, Dembinski JL, Woodward WA, Munshi A, Meyn RE, Cox JD, Andreeff M, Marini FC. Tumor irradiation increases recruitment of circulating MSC into tumor microenvironment. Cancer Research 67(24):11687-11697, 2007. e-Pub 2007. PMID: 18089798.
273. Liengsawangwong R, Yu TK, Sun TL, Erasmus J, Perkins GH, Tereffe W, Oh JL, Woodward WA, Strom EA, Salehpour M, Buchholz TA. Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer. Int J Radiat Oncol Biol Phys 69(3):711-715, 2007. e-Pub 2007. PMID: 17889264.
274. Oh JL, Nguyen G, Whitman GH, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GH, Buchholz TA. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420-2427. e-Pub 2007. PMID: 17941034.
275. Garg AK, Oh JL, Oswald MJ, Huang E, Strom EA, Perkins GH, Woodward WA, Yu TK, Tereffe W, Meric-Bernstam F, Hahn K, Buchholz TA. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy. Int J Radiat Oncol Biol Phys 69(5):1478-1483, 2007. e-Pub 2007. PMID: 17855016.
276. McGuire SE, Gonzales-Angulo AM, Tucker SL, Kau SW, Yu TK, Strom EA, Oh J, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin A, Hortobagyi GH, Buchholz TA. Post-mastectomy radiation improves the outcome of patients with stage III breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68(4):1004-1009, 2007. e-Pub 2007. PMID: 17418973.
277. Sher T, Henessy BT, Valero V, Brogio K, Woodward WA, Trent J, Hunt KK, Hortobagyi GN, Gonzales-Angulo AM. Primary angiosarcomas of the breast. Cancer 110(1):173-178, 2007. e-Pub 2007. PMID: 17541936.
278. Truong PT, Woodward WA, Thames HD, Ragaz J, Olivotto TA, Buchholz TA. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: An analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 68(1):59-65, 2007. e-Pub 2007. PMID: 17321065.
279. Borghero YO, Salehpour M, McNeese MD, Stovall M, Smith SA, Johnson J, Perkins GH, Strom EA, Oh JL, Kirsner SM, Woodward WA, Yu TK, Buchholz TA. Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparison. Radiother Oncol 82(3):324-8, 2007. e-Pub 2007. PMID: 17157944.
280. Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TA. Local-regional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Rad Oncol Biol Phys 67(2):490-496, 2007. e-Pub 2007. PMID: 17236970.
281. WA* W, MS* C, Behbod F, Alfaro MP, Buchholz TA, (*co-first authors) RJ. WTN/B-catenin mediates radiation resistance of mouse mammary progenitor cells. PNAS 104(2):618-623, 2007. e-Pub 2007. PMID: 17202265.
282. MS* C, WA* W, Behbod F, Peddibhotla S, Alfaro M, Buchholz TA, (*co-first authors) RJ. Wnt/B-catenin mediates radiation resistance of Sca1+ progenitors in immortalized mammary gland cell line. J Cell Science 120(3):468-477, 2007. e-Pub 2007. PMID: 17227796.
283. Woodward WA, Huang EH, McNeese MD, Perkins GH, Tucker SL, Strom EA, Middleton L, Hahn K, Hortobagyi GN, Buchholz TA. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer 107(11):2662-8, 2006. e-Pub 2006. PMID: 17061247.
284. Woodward WA, Huang EH, McNeese MD, Perkins GH, Tucker SL, Strom EA, Middleton L, Gwyn K, Hortobagyi GN, Buchholz TA. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer 107(11):2662-2668, 2006. e-Pub 2006. PMID: 17021247.
285. Oh JL, Dryden MJ, Woodward WA, Yu TK, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH, Oswald MJ, Domain D, Buchholz TA. Local-regional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and local-regional therapy. J Clin Oncol 24(31):4971-4975, 2006. e-Pub 2006. PMID: 17075114.
286. Buchholz TA, Strom EA, Oswald MJ, Perkins GH, Oh J, Domain D, Tk Y, Woodward WA, Tereffe W, Singletary SE, Thomas E, Buzdar AU, Hortobagyi GN, McNeese MD. Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 65(4):1155-1160, 2006. e-Pub 2006. PMID: 16750325.
287. Woodward WA, Giordano SH, Duan Z, Hortobagyi GN, Buchholz TA. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Cancer 106(12):2556-2562, 2006. e-Pub 2006. PMID: 16691617.
288. Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, Theriault R, Singletary E, Sahin A, McNeese MD. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 63(5):1508-1513, 2005. e-Pub 2005. PMID: 16169678.
289. Woodward WA, Chen MS, Behbod F, Rosen JM. On mammary stem cells. J Cell Sci 118(Pt 16):3585-94, 2005. e-Pub 2005. PMID: 16105882.
290. Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TA. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57:336-44, 2003. e-Pub 2003. PMID: 12957243.
291. Woodward WA, Strom EA, McNeese MD, Perkins GH, Outlaw EL, Hortobagyi GN, Buzdar AU, Buchholz TA. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys 57:327-35, 2003. e-Pub 2003. PMID: 12957242.
292. Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter NR, Singletary SE, Theriault RL, Hortobagyi GN, Hunt KK, Buchholz TA. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 21:3244-8, 2003. e-Pub 2003. PMID: 12947058.
293. Woodward WA, Tuan RS. N-Cadherin expression and signaling in limb mesenchymal chondrogenesis: stimulation by poly-L-lysine. Dev Genet 24(1-2):178-87, 1999. e-Pub 1999. PMID: 10079520.

Invited Articles

1. Lievens Y, Guckenberger M, Gomez D, Hoyer M, Iyengar P, Kindts I, Méndez Romero A, Nevens D, Palma D, Park C, Ricardi U, Scorsetti M, Yu J, Woodward WA. Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document. Radiother Oncol 148:157-166, 2020. e-Pub 2020. PMID: 32388150.
2. Mamounas EP, Mitchell MP, Woodward WA. Molecular Predictive and Prognostic Markers in Locoregional Management. J Clin Oncol 38(20):JCO1902905, 2020. e-Pub 2020. PMID: 32442060.
3. Bergom C, West CM, Higginson DS, Abazeed ME, Arun B, Bentzen SM, Bernstein JL, Evans JD, Gerber NK, Kerns SL, Keen J, Litton JK, Reiner AS, Riaz N, Rosenstein BS, Sawakuchi GO, Shaitelman SF, Powell SN, Woodward WA. The implications of genetic testing on radiotherapy decisions: a guide for radiation oncologists. Int J Radiat Oncol Biol Phys 105(4):698-712, 2019. e-Pub 2019. PMID: 31381960.
4. Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, Ueno NT, Lim B. Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer. Surg Clin North Am 98(4):787-800, 2018. e-Pub 2018. PMID: 30005774.
5. Lim B, Woodward WA, Wang X, Reuben JM, Ueno NT. Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is key. Nat Rev Cancer 18(8):526, 2018. e-Pub 2018. PMID: 29748602.
6. Lim B, Woodward WA, Wang X, Reuben JM, Ueno NT. Effect of statins on breast cancer recurrence and mortality: a review. Nat Rev Cancer 18(8):485-499, 2018. e-Pub 2018. PMID: 29703913.
7. Van Wyhe RD, Caudle AS, Shaitelman SF, Perkins GH, Buchholz TA, Hoffman KE, Strom EA, Smith BD, Tereffe W, Woodward WA Stauder MC. A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer. Adv Radiat Oncol 3(3):252-257, 2018. e-Pub 2018. PMID: 30197937.
8. Horton JK, Jagsi R, Woodward WA, Ho A. Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy. Int J Radiat Oncol Biol Phys 100(1):23-37, 2018. e-Pub 2018. PMID: 29254776.
9. Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 9(8):1437-1447, 2018. e-Pub 2018. PMID: 29721054.
10. Oualla K, El-Zawahry HM, Arun B, Reuben JM, Woodward WA, Gamal El-Din H, Lim B, Mellas N, Ueno NT, Fouad TM. Novel therapeutic strategies in the treatment of triple-negative breast cancer. Ther Adv Med Oncol 9(7):493-511, 2017. e-Pub 2017. PMID: 28717401.
11. Woodward WA. Inflammatory Breast Cancer: Unique Biological and Therapeutic Considerations. Lancet Oncol 16(15):e568-e576, 2015. e-Pub 2015. PMID: 26545845.
12. Wolfe AR, Woodward WA. Breast Cancer Stem Cell Correlates as Predicative Factors for Radiation Therapy. Semin Radiat Oncol 25(4):251-9, 2015. e-Pub 2015. PMID: 26384273.
13. Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA, Iwamoto T, Krishnamurthy S, Yang W, Reuben JM, Hortobágyi GN, Ueno NT. Inflammatory breast cancer: what we know and what we need to learn. Oncologist 17(7):891-9, 2012. e-Pub 2012. PMID: 22584436.
14. Woodward WA, Buchholz TA. Should breast conservation be offered to young women with breast cancer?. Breast Cancer Res Treat 127(1):217-9, 2011. e-Pub 2011. PMID: 20945088.
15. Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22(3):515-23, 2011. e-Pub 2011. PMID: 20603440.
16. Woodward WA. Breast cancer stem cell targets. Oncology (Williston Park) 25(1):34, 36, 2011. e-Pub 2011. PMID: 21361241.
17. Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno N, Cristofanilli M. Inflammatory Breast Cancer: the disease, the biology, the treatment. CA Cancer J Clin 60(6):351-75, 2010. e-Pub 2010. PMID: 20959401.
18. Lacerda L, Pusztai L, Woodward WA. The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches. Drug Resist Updat. e-Pub 2010. PMID: 20739212.
19. Woodward WA, Debeb BG, Xu W, Buchholz TA. Overcoming radiation resistance in inflammatory breast cancer. Cancer 116(11 Suppl):2840-5, 2010. e-Pub 2010. PMID: 20503417.
20. Xu W, Debeb BG, Lacerda L, Woodward WA. Potential targets for improving radiosensitivity of breast tumor-initiating cells. Anticancer Agents Med Chem 10(2):152-6, 2010. e-Pub 2010. PMID: 20184537.
21. Vinh-Hung V, Nguyen NP, Cserni G, Truong P, Woodward WA, Verkooijen HM, Promish D, Ueno NT, Tai P, Nieto Y, Joseph S, Janni W, Vicini F, Royce M, Storme G, Wallace AM, Vlastos G, Bouchardy C, Hortobagyi GN. Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol 5(10):1585-603, 2009. e-Pub 2009. PMID: 20001797.
22. Woodward WA, Cristofanilli M. Inflammatory breast cancer. Semin Radiat Oncol 19(4):256-265, 2009. e-Pub 2009. PMID: 19732690.
23. Woodward WA, Bristow RG, Clarke MF, Coppes RP, Cristofanilli M, Duda DG, Fike JR, Hambardzumyan D, Hill RP, Jordan CT, Milas L, Pajonk F, Curran WJ, Dicker AP, Chen Y. Radiation Therapy Oncology Group Translational Research Program Stem Cell Symposium: Incorporating Stem Cell Hypotheses into Clinical Trials. Int J Radiat Oncol Biol Phys 74(5):1580-91, 2009. e-Pub 2009. PMID: 19540073.
24. Woodward WA, Bristow RG. Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg Uncertainly Principle has to do with Biology). Semin Radiat Oncol 19(2):87-95, 2009. e-Pub 2009. PMID: 19249646.
25. Debeb BG, Xu W, Woodward WA. Radiation resistance of breast cancer stem cells: understanding the clinical framework. J Mammary Gland Biol Neoplasia 14(1):11-7, 2009. e-Pub 2009. PMID: 19252973.
26. Woodward WA, Sulman EP. Cancer stem cells: markers or biomarkers?. Cancer Metastasis Rev 27(3):459-70, 2008. e-Pub 2008. PMID: 18437295.
27. Woodward WA, Buchholz TA. The role of locoregional therapy in inflammatory breast cancer. Semin Oncol 35(1):78-86, 2008. e-Pub 2008. PMID: 18308149.
28. Reuben JM, Krishnamurthy S, Woodward WA, Cristofanilli M. The role of circulating tumor cells in breast cancer diagnosis and prediction of therapy response. Expert Opinion on Medical Diagnosis. 2. Infoma UK Ltd:339-348, 2008. e-Pub 2008.
29. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P, Vlastos G, Wallace AM, Hortobagyi GN, Nieto Y. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24:2910-6, 2006. e-Pub 2006. PMID: 16782931.
30. Truong PT, Woodward WA, Buchholz TA. Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy. Expert Rev Anticancer Ther 6(2):205-216, 2006. e-Pub 2006. PMID: 16445373.
31. Woodward WA, Chen MS, Behbod F, Rosen JM. Commentary: On mammary stem cells. J Cell Sci 118(16):3585-3594, 2005. e-Pub 2005.
32. Woodward WA, Wachsberger P, Burd R, Dicker AP. Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade. Prostate Cancer Prostatic Dis 8:127-32, 2005. e-Pub 2005. PMID: 15643450.

Manuals, Teaching Aids, Other Teaching Publications

1. Woodward WA. Breast Cancer Radiotherapy: Treatment Approaches, 2011.

Other Articles

1. Shaitelman, SF, Woodward, W Neoadjuvant radioimmunotherapy synergy in triple-negative breast cancer. Cancer cell 42(1):10-12, 2024. PMID: 38194911.
2. Woodward, W Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. Breast Diseases 25(2):125, 2014.
3. Woodward, W Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. Breast Diseases 25(1):36-37, 2014.
4. Debeb, BG, Woodward, W ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome. Breast Diseases 25(1):47-48, 2014.

Editorials

1. Woodward WA. Between a Rock and a Hard Place. Int J Radiat Oncol Biol Phys 101(2):266, 2018. PMID: 29726355.
2. Ovalle V, Strom EA, Godby J, Shaitelman SF, Stauder MC, Amos RA, Kuerer HM, Woodward WA, Hoffman KE. Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly?. Int J Radiat Oncol Biol Phys 95(1):49-51, 2016. PMID: 27084625.
3. Woodward WA, Amos RA. Proton Radiation Biology Considerations for Radiation Oncologists. Int J Radiat Oncol Biol Phys 95(1):59-61, 2016. PMID: 27084628.
4. Jagsi R, Woodward WA. Breast Radiation Therapy-Sometimes Less May Be More. Int J Radiat Oncol Biol Phys 93(1):1-3, 2015. PMID: 26279015.
5. Woodward WA. Should surgery referral be standard practice in metastatic inflammatory breast cancer?. Ann Surg Oncol 22(8):2466-7, 2015. PMID: 25794829.
6. Woodward WA. Post-mastectomy radiation therapy for inflammatory breast cancer - is more better?. Int J Radiat Oncol Biol Phys 89(5):1004-1005, 2014. PMID: 25035202.
7. Woodward WA, Tan EY, Seng Hosp BSTAO(T, al) SE. Editorial: ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome, Br J Cancer 109: 109-113, 2013. Breast Diseases: A Yearbook Quarterly 25(1):47-48, 2014.
8. Woodward WA, Stearns V, Jacobs LK, Fackler MJ, of Medicine EA(HUS, Baltimore, al) ME. Editorial: Biomarker Modulation following Shirt-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer, Clin Cancer Res 19:4008-4016, 2013. Breast Diseases: A Yearbook Quarterly 25(1):36-37, 2014.
9. Hunt KK, Woodward WA. Have we made progress in inflammatory breast cancer? Not so fast. Oncology (Williston Park) 25(3):276-278, 2011. PMID: 21548471.
10. Woodward WA, Moran MS, Yang Q, Harris LN, of Medicine EA(US, Haven N, Univ CS, Jinan, China:et al) PRO. Editorial: Long-term Outcomes and Clinicopathologic Differences of African-American Versus White Patients Treated with Breast Conservation Therapy for Early-Staged Breast Cancer, Cancer 113;2565-2574, 2008. Breast Diseases: A Yearbook Quarterly 20(2):146-147, 2009.
11. Woodward WA, Nilsson G, Holmberg L, Garmo H, (Univ Hosp EA, al) SE. Editorial: Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke, BR J Cancer 100:811-816, 2009. Breast Diseases: A Yearbook Quarterly 20(4):447-448, 2009.
12. Woodward WA. Prognosis of Breast Cancer After Supraclavicular Lymph Node Metastasis: Not a Distant Metastasis. Breast Diseases: A Yearbook Quarterly 18(4):388, 2008.
13. Woodward WA. 3-50 Decreased Risk of Stroke among 10-Year Survivors of Breast Cancer. Breast Diseases. Breast Diseases: A Yearbook Quarterly 18(3):294-295, 2007.
14. Woodward WA. Local Recurrence of Breast Cancer After MammoSite Brachytherapy. Breast Diseases: A Yearbook Quarterly 18(2):195, 2007.
15. Woodward WA. Tumor Bed Boost Omission After Negative Re-Excision in Breast Conservation Treatment. Breast Diseases: A Yearbook Quarterly 18(1):81-82, 2007.
16. Woodward WA. Editorial: "Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT).". Breast Diseases: A Yearbook Quarterly 17(2):177-178, 2006.
17. Woodward WA. Predicting Biopsy Outcome After Mammography: What is the likelihood the Patient has Invasive or In Situ Breast Cancer?. Breast Diseases: A Yearbook Quarterly 17(1):71, 2006.
18. Woodward WA. Regarding "Should post-mastectomy radiation be used for node-negative breast cancer patients?". The Women's Oncology Review 6(1-2):81-82, 2006.
19. Woodward WA. Regarding "Post-mastectomy radiation for breast cancer patients with small tumors and one to three positive lymph nodes.". The Women's Oncology Review 6(1-2):79-80, 2006.
20. Woodward WA. Commentary on: "The management of elderly patients with T1-T2 breast cancer treated with or without radiotherapy.". Breast Diseases: A Yearbook Quarterly 16(4):368-369, 2006.
21. Woodward WA. The Management of Elderly Patients with Y1-T2 Breast Cancer Treated With or Without Radiotherapy. Breast Diseases: A Yearbook Quarterly 16(4):368-369, 2006.
22. Woodward WA. Commentary on: "Predicting biopsy outcome after mammography: What is the likelihood the patient has invasive or in situ breast cancer?". Breast Diseases: A Yearbook Quarterly 17(1):71, 2006.
23. Woodward WA, Desai P, Chlebowski R, Cauley JA, Med College EA(C, of California NU, Angeles L, Med Ctr SBU, al) NE. Editorial: Prospective Analysis of Association between Statin Use and Breast Cancer Risk in the Women’s Health Initiative, Cancer Epidemiol Biomarkers Prev 22:1868-1876, 2013. Breast Diseases: A Yearbook Quarterly 25(2), 2004.

Abstracts

1. Shaitelman SF, Gandhi A, DeSnyder S, Smith GL, Lin R, Barcenas C, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward BS, Perkins GH, Mitchell MP, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I. Prospective, Longitudinal Assessment of Lymphedema-related Quality of Life for Locally Advanced Breast Cancer Patients: A Foundation for Needed Elements in a Lymphedema Screening Program. American Radium Society 2022 Annual Meeting, 2022. e-Pub 2022.
2. Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt K, Lucci A, Teshome M. ASO Visual Abstract: Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol 29(1):389, 2022. e-Pub 2022. PMID: 34743277.
3. Rahal OM, Wolfe AR, Mandal PK, Larson R, Tin S, Reuben JM, McMurray JS, Woodward WA. Understanding the complexity of macrophage and mesenchymal stem cell interactions to improve treatment outcome for IBC patients. 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
4. Alexander A, Willey JS, Sun H, Parker CA, Marx AN, Wood AL, Reddy SM, Reuben JM, Bassett RL, Le_Petross HT, Krishnamurthy S, Gong Y, Woodward WA, Valero V, Ueno NT, Lim B. A single arm phase II study of adjuvant anti-PD1 (pembrolizumab) in combination with hormonal therapy in patients with hormone receptor (HR)-positive localized inflammatory breast cancer (IBC) who did not achieve a pathologicalcomplete response (pCR) to neoadjuvant chemotherapy. 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
5. Willey JS, Parker CA, Lim B, Valero V, Le-Petross HT, Krishnamurthy S, Woodward WA, Lucci A, Wood AL, Sun H, Babiera GV, Song J, Shen Y, Valero V, Wang, Ueno NT. A randomized phase II study of neoadjuvant panitumumab /carboplatin/paclitaxel (PaCT) versus carboplatin/paclitaxel (CT) followed by adriamycin and cyclophosphamide (AC) for newly diagnosed primary triple-negative inflammatory breast cancer (TNIBC). 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
6. Grossberg A, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom E, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD. Prospective Validation of Transforming Growth Factor-Beta (TGF-β) Polymorphism C509T as a Predictor of Radiation-Induced Fibrosis in Early Stage Breast Cancer Patients. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
7. Shaitelman S, Lei X, Thompson, A, Schlembach P, Arzu I, Bloom ES, Buchholz DJ, Chronowski, GM, Dvorak T, Grade EJ, Hoffman KE, Kelly P, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA; Baumann D, Amaya D, Guerra W, Morrison M, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Three-year outcomes with hypofractionated (HF) versus conventionally fractionated (CF) whole breast irradiation (WBI). 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
8. Cohen, EN, Jayachandran G, Gao H, Tin S, Alvarez, RH, Valero V, Lim B, Woodward WA, Ueno NT, Reuben JM. Circulating protein biomarker profile for inflammatory breast cancer using a multiplexed proximity extension assay. 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
9. Stecklein SR, Babiera GV, Bedrosian I, Shaitelman SF, Ballo MT, Tereffe W, Arzu IY, Perkins GH, Strom EA, Reed VK, Dvorak T, Smith BD, Woodward WA, Hoffman KE, Schlembach PJ, Chronowski GM, Shah SJ, Kirsner SM, Nelson CL, Guerra W, Dibaj SS, Bloom ES. Prospective comparison of late toxicity and cosmetic outcome after accelerated partialbreast irradiation with conformal. 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
10. Eckhardt BL, Torres AM, Woodward WA, Krishnamurthy S, Meric-Bernstam F, Ueno NT. EphA2: An emerging target in triple-negative breast cancer. 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
11. Reddy SM, Reuben A, Jiang H, Roszik J, Tetzlaff MT, Reuben J, Wang L, Tsujikawa T, Barua S, Rao A, Villareal L, Wood A, Woodward WA, Ueno NT, Krishnamurthy S, Wargo JA, Mittendorf EA. Lymphoid and myeloid cell characterization of inflammatory breast cancer tumor microenvironment and correlation to pathological complete response. 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
12. Willey JS, Parker CA, Valero V, Lim B, Reuben JM, Krishnamurthy S, Gong Y, Scoggins ME, Dryden MJ, Liu DD, Woodward WA, Ueno NT. A phase II study of anti-PD-1 (MK-3475) therapy in patients with metastatic inflammatory breast cancer (MIBC) or non-IBC triple negative breast cancer (non-IBC TNBC) who have achieved clinical response or stable disease to prior chemotherapy. 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
13. Rahal, OM, Wolfe AR, Mandal PK, Larson R, Tin S, Jimenez C, Zhang D, Horton J, Reuben JM, McMurray JS, Woodward WA. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
14. Willey JS, Marx AN, Lim B, Ibrahim NK, Valero V, Mittendorf EA, Reuben JM, Le-Petross HT, Whitman GJ, Krishnamurthy S, Woodward WA, Lucci A, Liu DD, Shen Y, Ueno NT. A phase II study using talimogene laherparepvec as a single agent for inflammatory breast cancer or non-inflammatory breast cancer patients with inoperable local recurrence. 2017 San Antonio Breast Cancer Symposium, 2017. e-Pub 2017.
15. Grossberg A, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom E, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD. Prospective Validation of Transforming Growth Factor-Beta (TGF-β) Polymorphism C509T as a Predictor of Radiation-Induced Fibrosis in Early Stage Breast Cancer Patients. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
16. Christopherson KM, Lei X, Barcenas CH, Buchholz TA, Hoffman KE, Kuerer HM, Mittendorf EA, Perkins GH, Shaitelman SF, Smith GL, Stauder MC, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of Curative-Intent Treatment for Breast Cancer Patients Presenting with Sternal or Mediastinal Involvement. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
17. Van Wyhe RD, Brewster AM, Allen PK, Arun BK, El-Zein R, Woodward WA, Buchholz TA, Stauder MC. Nijmegen Breakage Syndrome 1 (NBS1) Gene Polymorphism and Overall Survival in Breast Cancer. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
18. Christopherson KM, Lei X, Barcenas CH, Buchholz TA, Hoffman KE, Kuerer HM, Shaitelman SF, Perkins GH, Smith GL, Stauder MC, Strom EA, Tereffe W, Woodward WA, Smith BD. (S003) Curative-Intent Treatment for Newly Diagnosed Breast Cancer With Limited Metastatic Disease to the Sternum or Mediastinum. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
19. Van Wyhe RD, Shaitelman SF, Caudle AS, Hoffman KE, Perkins GH, Tereffe W, Smith BD, Strom EA, Buchholz TA, Woodward WA, Stauder MC. (S042) Invasive Lobular Carcinoma Predicts for an Increased Likelihood of Surgical Upstaging Requiring Post-Mastectomy Radiation Therapy. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
20. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. (P015) Radiotherapy After Skin-Sparing Mastectomy and Placement of a Tissue Expander: Effectiveness of a Coordinated, Multidisciplinary Approach. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
21. Woodward WA, Fang P, Arriaga L, Gao H, Cohen EN, Reuben JM, Valero V, Le-Petross H, Middleton LP, Babiera GV, Strom EA, Tereffe W, Hoffman KE, Smith BD, Buchholz TA, Perkins GH. A Phase 2 Study of Preoperative Capecitabine and Concomitant Radiation in Women With Advanced Breast Cancer. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
22. Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology–Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
23. Stecklein SR, Park M, Liu DD, Valle JJ, Caudle AS, Mittendorf EA, Barcenas CH, Woodward WA, Valero V, Shaitelman SF. Impact of Regional Nodal Irradiation After Neoadjuvant Chemotherapy in Breast Cancer Patients With Cytologically Confirmed Axillary Lymph Node Metastases. Proceedings of the 59th Annual Meeting of the American Society for Radiation Oncology, 2017. e-Pub 2017.
24. Swanick CW, Lei X, Shaitelman SF, Schlembach P, Bloom ES, Fingeret M, Strom EA, Tereffe W, Woodward WA, Stauder MC, Dvorak, T, Buchholz TA, Smith BD. Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Proceedings of the 58th Annual Meeting of the American Society for Radiation Oncology, 2016. e-Pub 2016.
25. Woodward WA, Barlow WE, Jagsi, R, Buchholz, TA, Shak S, Baehner F, Yoshizawa CN, Whelan TJ, Davidson NE, Ingle JN, King TA, Ravdin PM, Osborne CK, Tripathy D, Livingston RB, Gralow, JR, Hortobagyi GN, Hayes DF, Albain KS. The 21-Gene Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer Treated on SWOG S8814. Proceedings of the 58th Annual Meeting of the American Society for Radiation Oncology, 2016. e-Pub 2016.
26. Moreno AC, Lin H, Bedrosian I, Smith BD, Babiera G, Stauder MC, Buchholz TA, Woodward WA, Shen Y, Shaitelman SF. Effect of Regional Nodal Irradiation on Overall Survival in Patients With High-risk Invasive Breast Cancer: A National Cancer Data Base Analysis. Proceedings of the 58th Annual Meeting of the American Society for Radiation Oncology, 2016. e-Pub 2016.
27. Shaitelman SF, Stauder MC, Allen PK, Reddy S, Lakoski SG, Atkinson BJ, Moulder S, Reddy J, Amaya D, Guerra W, Ueno NT, Caudle AS, Tereffe W, Woodward WA. Impact of Statin Use on Outcomes in Triple-Negative Breast Cancer. Proceedings of the 58th Annual Meeting of the American Society for Radiation Oncology, 2016. e-Pub 2016.
28. Craft DF, Woodward WA, Kanke J, Kry S, Howell RM. Use of Flexible 3D Printed Materials for In-House Fabrication of Patient-Specific Tissue Equivalent Compensators for Post-Mastectomy Radiation Therapy. Proceedings of the 58th Annual Meeting of the American Society for Radiation Oncology, 2016. e-Pub 2016.
29. Caceres S, Pena L, Illera MJ, Silvan G, de Andres PJ, Gao H, Woodward WA, Reuben JM, Illera JC. Male mouse model of canine and human inflammatory breast cancer (IBC). AACR 107th Annual Meeting on Bioinformatics and Systems Biology, 2016. e-Pub 2016.
30. Caceres S, Pena L, Illera M, Monsalve B, Woodward WA, Reuben J, Illera J. Flutamide effects on cell proliferation and steroid hormone secretion in human and canine inflammatory breast cancer cell lines. 10th European Breast Cancer Conference (EBCC), 2016. e-Pub 2016.
31. Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Larson R, Chu K, Huo L, Smith D, Li L, Ivan C, Allen P, Zhang X, Calin G, Krishannnurthy S, Buchholz T, Ueno N, Reuben J, Woodward WA. A novel mediator of brain metastasis from breast cancer. AACR Special Conference on Tumor Metastasis, 2016. e-Pub 2016.
32. Menen, R, Lin HY, Shen Y, Shaitelman SF, Bedrosian I, Woodward WA, Ueno N, Valero V, Babiera G. Resection of the Primary Tumor Significantly Improves Median Overall Survival in Patients with Stage IV De Novo Inflammatory Breast Cancer. 69th Annual Cancer Symposium of the Society-of-Surgical-Oncology, 2016. e-Pub 2016.
33. Chmura SJ, Winter KA, Salama, JK, Woodward WA, Borges VF, Al-Hallaq H, Matuszak M, Jaskowiak NT, Milano MT, Bandos H, White JR. NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer. 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2015. e-Pub 2015.
34. Rahal OM, Wolfe AR, Larson RA, Ueno NT, Reuben JM, Woodward WA. Lipoproteins regulate the effects of macrophages and mesenchymal stem cells on radiation response of inflammatory breast cancer cells. 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2015. e-Pub 2015.
35. Anfossi S, Huo L, Woodward WA, Ueno NT, Valero V, Calin GA, Reuben JM. High serum miR-19a levels correlated with favorable prognosis in patients with metastatic HER2+breast cancer and might result from effective antibody-dependent cell-mediated cytotoxicity (ADCC) induced by trastuzumab and Th1-mediated antitumor immune response. 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2015. e-Pub 2015.
36. Wolfe A, Bambhroliya A, Reddy J, Debeb BG, Woodward WA. MiR-33a Regulates Radiation Sensitivity to High Density Lipoprotein in Breast Cancer. 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2015. e-Pub 2015.
37. Cai CY, Calhoun JD, Kanke J, Melancon AD, Collado D, Gifford K, Semien K, Potocsny N, Stauder MC, Guzman AB, Randolph CL, Sobremonte A, Marsh GD, Woodward WA, Feeley TW, Shaitelman SF. Defining Cost as a First Step to Determining the Value of Radiation Services Provided: Utilizing Time-Driven Activity-Based Costing to Ascertain True Costs in Breast Cancer Radiation Treatment Planning. Proceedings of the 58th Annual Meeting of the American Society for Radiation Oncology, 2015. e-Pub 2015.
38. Stecklein SR, Reddy J, Wolfe A, Lopez MS, Fouad TM, Debeb BG, Brewster AM, Ueno NT, Woodward WA. Lack of Breastfeeding History in Parous Women With Inflammatory Breast Cancer Predicts Locoregional Recurrence and Distant Metastasis. 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2015. e-Pub 2015.
39. Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho AY, Schott A, Pierce LJ. TBCRC 024 Initial Results: A Multicenter Phase 1 Study of Veliparib Administered Concurrently With Chest Wall and Nodal Radiation Therapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer. 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2015. e-Pub 2015.
40. Arthur DW, Winter K, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White JR. NRG Oncology/RTOG 1014: 1-Year Toxicity Report From a Phase II Study of Repeat Breast Preserving Surgery and 3D Conformal Partial-Breast Reirradiation (PBrI) for In-Breast Recurrence. 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2015. e-Pub 2015.
41. Pan HY, Edwards TJ, Giragosian DP, Holliday E, Swanick CW, Martin GV, Hoffman KE, Shaitelman SF, Woodward WA, Smith BD. Improving Clinical Documentation and Prospectively Populating a Research Database Using an Electronic Data Capture System for Routine Clinical Care. 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2015. e-Pub 2015.
42. Lin HY, Babiera G, Bedrosian I, Shaitelman SF, Kuerer HM, Woodward WA, Ueno NT, Shen Y. Factors influencing treatment of inflammatory breast cancer in the United States. Breast Cancer Symposium of the American-Society-of-Clinical-Oncology (ASCO), 2015. e-Pub 2015.
43. Smith D, Debeb B, Larson R, Diagaradjane P, Woodward WA. Prophylactic Cranial Irradiation Reduces the Incidence of Brain Metastasis in a Mouse Model of Metastatic Breast Cancer. 57th Annual Meeting and Exhibition of the American-Association-of-Physicists-in-Medicine (AAPM), 2015. e-Pub 2015.
44. Smith D, Debeb B, Woodward WA. Radiobiological Modeling of Prophylactic Cranial Irradiation in Mice. 57th Annual Meeting and Exhibition of the American-Association-of-Physicists-in-Medicine (AAPM), 2015. e-Pub 2015.
45. French JT, Hess KR, Liu DD, Raghav KPS, Hortobagyi GN, Arun B, Valero V, Ueno NT, Alvarez RH, Woodward WA, Debeb BG, Moulder SL, Lim B, Tripathy D, Ibrahim NK. Development of CNS metastasis and subsequent survival in patients with inflammatory breast cancer. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2015. e-Pub 2015.
46. Matsuda N, Alvarez RH, Krishnamurthy S, Willey JS, Wang X, Lim B, Parker CA, Marx A, Babiera G, Booser DJ, Murray JL, Arun B, Brewster AM, Reuben JM, Woodward WA, Lucci Jr A, Gainer SM, Tripathy D, Valero V, Ueno NT. Phase II Study of Panitumumab, Nab-paclitaxel, and Carboplatin Followed by FEC Neoadjuvant Chemotherapy for Patients with Primary HER-2 Negative Inflammatory Breast Cancer. Proceedings 2015 ASCO Annual Meeting, 2015. e-Pub 2015.
47. Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Huo L, Wei CM, Larson R, Wolfe A, Xu W, Li L, Smith D, Ivan C, Allen P, Krishnamurthy S, Calin G, Zhang X, Buchholz T, Ueno N, Reuben J, Woodward WA. MicroRNA 141: A novel regulator of brain metastasis from breast cancer. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), 2015. e-Pub 2015.
48. Anfossi S, Giordano A, Huo L, Alvarez RH, Valero V, Hortobagyi GN, Woodward WA, Ueno NT, Calin GA, Reuben JM. High miR-19a serum levels correlate with favorable prognosis in patients with metastatic HER2(+) inflammatory breast cancer and may result from an effective antibody-dependent cell-mediated cytotoxicity induced by trastuzumab. 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2014. e-Pub 2014.
49. Stauder MC, Shaitelman SF, Allen PK, Brewster AM, Arun BK, Woodward WA, Buchholz TA, Wang LE. Gamma-ray induced mutagen sensitivity and overall survival in young women with breast cancer. 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2014. e-Pub 2014.
50. Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Huo L, Wei CM, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Zhang XH, Calin GA, Krishnamurthy S, Ueno NT, Buchholz TA, Reuben JM, Woodward WA. The microRNA miR-141 is a key regulator of brain metastasis from breast cancer. 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2014. e-Pub 2014.
51. Alvarez RH, Chavez-MacGregor M, Ensor J, Murray JL, Koenig K, Krishnamurty S, Lucci A, Babiera GV, Woodward WA, Whitman GJ, Jackson SA, Shi M, Culver K, Reuben JL, Ueno NT, Valero V. A phase II study of dovitinib as salvage therapy in patients with stage IV inflammatory breast cancer HER2-negative with local or distant relapse. 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2014. e-Pub 2014.
52. Wolfe AR, Atkinson R, Debeb BG, Zhang Y, Ruffel B, Reuben JM, Ueno NT, Woodward WA. Mesenchymal stem cells and macrophage interactions promote inflammatory breast cancer cell invasion and self renewal. 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2014. e-Pub 2014.
53. Caceres S, Pena L, de la Cerda LCA, Illera MJ, Larson R, Gao H, Debeb BG, Woodward WA, Reuben JM, Illera JC. Characterization of a new canine inflammatory mammary cancer (IMC) cell line (IPC-366). 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2014. e-Pub 2014.
54. Porche BA, Allen PK, Shaitelman S, Guadagnolo BA, Woodward WA, Albarracin C, Brewster AM, Hunt KK, Tereffe W. Long term outcomes in patients with phyllodes tumor of the breast: The UT MD Anderson experience. 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2014. e-Pub 2014.
55. Mego M, Gao H, Cohen EN, Anfossi S, Giordano A, Tin S, Fouad TM, Woodward WA, Alvarez RH, Valero V, Ueno NT, Hortobagyi GN, Cristofanilli M, Reuben JM. Circulating tumor cells (CTC) are associated with defects in innate and adaptive immunity in inflammatory breast cancer (IBC) patients. 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2014. e-Pub 2014.
56. Howell RM, Tereffe W, Stauder MC, Stingo F, Strom EA, Perkins GH, Smith BD, Woodward WA, Hoffman KE, Buchholz TA, Salehpour MR, Kry SF, Barcenas CH, Yusuf WS, Shaitelman SF. What is normal? Cooperative pooled database to establish typical heart and lung doses for modern radiation therapy. Proceedings of ASTRO 2014, 2014. e-Pub 2014.
57. Stauder MC, Shaitelman SF, Allen PK, Smith BD, Hoffman KE, Buchholz TA, Chavez-Macgregor M, Middleton LP, Caudle AS, Hunt KK, Meric-Bernstam F, Woodward WA. Post-mastectomy radiotherapy after positive sentinel lymph node biopsy and completion axillary lymph node dissection. Proceedings of ASTRO 2014, 2014. e-Pub 2014.
58. Cupp JA, Liu D, Shen Y, Ueno NT, Alvarez RH, Chavez-Mac Gregor M, Woodward WA, Kogawa T, Babiera G. Factors influencing survival in inflammatory breast cancer. Breast Cancer Symposium, 2014. e-Pub 2014.
59. Shaitelman S, Buchholz TA, Hunt KK, Hortobagyi G, Schlembach P, Arzu I, Bloom E, Chronowski G, DvoraK T, Grade Hoffman K, Perkins G, Reed V, Shah S, Stauder M, Strom E, Tereffe W, Woodward WA, Smith BD. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months compared to conventionally fractionated whole breast irradiation: results of a randomized trial. Proceedings of ASTRO 2014, 2014. e-Pub 2014.
60. Thaker NG, Komaki R, Golden DW, Gunther JR, Hillebrandt E, Mahajan A, Frank SJ, Woodward WA. Improving the quality of radiation oncology education through an innovative medical student treatment planning curriculum. Proceedings of ASTRO 2014, 2014. e-Pub 2014.
61. Woodward WA, Sneige N, Winter K, Kuerer HM, Hudis C, Rakovitch E, Smith BL, Pierce LJ, Germano I, Pu AT, Walker EM, Grisell DL, White JR, McCormick B, Group (RTOG) FTRTO. Web based pathology assessment in RTOG 98-04. J Clin Pathol 67(9):777-780, 2014. e-Pub 2014. PMID: 24989024.
62. Strom EA, Amos RA, Shaitelman S, Kerr M, Hoffman K, Smith BD, Amin M, Wang X, Poenisch F, Woodward WA. Prospective Phase 2 Proton APBI: Multibeam Supine Treatment Is Reproducible and Free From Acute Toxicity. 56th Annual Meeting of the American-Society-for-Radiation-Oncology, 2014. e-Pub 2014.
63. Howell RM, Tereffe W, Stauder M, Stingo F, Strom E, Perkins GH, Smith BD, Woodward WA, Hoffman K, Buchholz TA, Salehpour M, Kry SF, Barcenas C, Hernando Y, Wamique S, Shaitelman SF. Toward developing survivorship care plans for breast cancer patients at high risk for radiation-related cardiac effects. Proceedings of ASTRO 2014, 2014. e-Pub 2014.
64. Wolfe A, Atkinson R, Reddy J, Brewster A, Ueno N, Woodward WA. Lipoproteins HDL and VLDL Have Opposing Roles in Regulating Sensitivity to Radiation In Vitro and Predict for Overall Survival in Patients With Inflammatory Breast Cancer. 56th Annual Meeting of the American-Society-for-Radiation-Oncology, 2014. e-Pub 2014.
65. Akay C, Ueno NT, Chisholm GB, Hortogagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt K, Huo L, Babiera GV. Primary tumor resection may improve survival and local disease control in stage IV inflammatory breast cancer. Cancer 9(120):1319-28, 2014. e-Pub 2014. PMID: 24510381.
66. Atkinson RL, Symmans F, Bevers TB, Woodward WA, Brewster AM. Prevalence of breast stem cells in high-risk benign breast lesions and association with breastfeeding. 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), 2014. e-Pub 2014.
67. Cohen EN, Gao H, Anfossi S, Giordano A, Tin S, Wu Q, Lee BN, Luthra R, Krishnamurthy S, Hortobagyi GN, Ueno NT, Woodward WA, Reuben JM. Immune-induced epithelial to mesenchymal transition in inflammatory breast cancer induces unique increases in E-cadherin, adhesion and migration through TNF-a, IL-6 and TGF-b. 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2013. e-Pub 2013.
68. Reyes ME, Zhang D, Eckhardt B, Masuda H, Pirman DA, Reuben JM, Woodward WA, Yang P, Hortobagyi GN, Wang X, Ueno NT. Celecoxib inhibits the growth of IBC tumors by suppressing the regulation of cancer stem-like cells by nodal. 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2013. e-Pub 2013.
69. Atkinson RL, Ei-Zein RA, Fouad TM, de Lacerda LCA, Wolfe AR, Bondy ML, Ueno NT, Woodward WA, Brewster AM. Risk factors for inflammatory breast cancer. 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2013. e-Pub 2013.
70. Anfossi S, Burks JK, Giordano A, Cohen EN, Gao H, Debeb BG, Woodward WA, Ueno NT, Ricardo AH, Hortobagyi GN, Valero V, Reuben JM. MiR-19a released by the triple negative inflammatory breast cancer SUM149 cells can be taken up by dendritic cells and induce increased synthesis of the proinflammatory cytokines IL-6 and TNF-a. 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2013. e-Pub 2013.
71. Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Arun B, Chavez-Macgregor M, Alvarez RH, Lucci A, Krishnamurthy S, Hortobagyi GN, Valero V, Ueno NT. Survival differences between patients with metastatic inflammatory and non-inflammatory breast cancer. 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2013. e-Pub 2013.
72. Lacerda L, Garza R, Cohen E, Atkinson R, Solley T, Li L, Debeb B, Xu W, Reuben J, Klopp A, Woodward WA. Expansion of tumor initiating cells is mediated by tumor microenvironment in breast cancer metastasis. 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2013. e-Pub 2013.
73. Masuda H, Gregor MCM, Liu DD, Alvarez RH, Krishnamurthy S, Lucci A, Woodward WA, Gildy B, Mittendorf EA, DeSnyder SM, Shen Y, Willey JS, Hortobagyi GN, Valero V, Ueno NT. Predictors of poor clinical outcome among patients with inflammatory breast cancer (IBC) who did and did not achieve pathological complete response (pCR) after neoadjuvant systemic chemotherapy. 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2013. e-Pub 2013.
74. Woodward WA, Arriaga L, Gao H, Cohen EN, Li L, Reuben JM, Munsell MF, Valero V, Le-Petross H, Melhem-Betrandt A, Moulder S, Middleton LP, Strom, EA, Tereffe W, Hoffman K, Smith BD, Buchholz TA, Perkins GH. Prospective phase II study of concurrent capecitabine and radiation demonstrates futility in triple negative chemo-resistant breast cancer. 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2013. e-Pub 2013.
75. Masuda H, Baggerly K, Wang Y, Iwamoto T, Brewer T, Pusztai L, Kai K, Woodward WA, Reuben JM, Van Laere SJ, Bertucci F, Hortobagyi GN, Ueno NT. Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers. Breast Cancer Research 6(15):112, 2013. e-Pub 2013. PMID: 24274653.
76. Nowicka A, Cortez A, Marini F, Sharp H, Solley T, Broaddus R, Kolonin M, Mok SAM, Schmandt R, Woodward WA, Lu K, Zhang YAN, Klopp AH. Human omental-derived adipose stem cells: modulator of ovarian cancer proliferation, migration and chemoresistance. Int J Gynecological Cancer, 2013. e-Pub 2013.
77. Thaker N, Hoffman KE, Pusztai L, Buchholz TA, Woodward WA. Complementing Ipsilateral Breast Tumor Recurrence (IBTR!) Estimates With the 21-Gene Recurrence Score (RS) in Early-Stage, Hormone Receptor-Positive, HER2-Normal, Lymph Node-Negative Breast Cancers. 55th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2013. e-Pub 2013.
78. Wolfe A, Woodward WA. Targeting Radiation-Resistant Breast Cancer Stem Cells With the Combination Erlotinib and Simvastatin. 55th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2013. e-Pub 2013.
79. Parinyanitikul N, Lei XD, Chavez-Mac Gregor M, Mittendorf EA, Litton JK, Woodward WA, Zhang H, Hortobagyi GN, Gonzalez-Angulo AM. Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy (NCT) and analysis of survival outcome. Breast Cancer Symposium, 2013. e-Pub 2013.
80. Reddy J, Dawood S, Mitchell M, Debeb B, Gonzalez-Angulo A, Sulman E, Buchholz T, Woodward WA. Antiepileptic Drug Use Improves Overall Survival in Breast Cancer Patients With Brain Metastases in the Setting of Whole Brain Radiation Therapy. 55th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2013. e-Pub 2013.
81. Chavez-MacGregor M, Parinyanitikul N, Lei X, Mittendorf E, Litton J, Woodward WA, Zhang A, Gonzalez-Angulo AM. Changes in breast cancer subtype between primary tumor and residual disease after neoadjuvant systemic chemotherapy (NSC). European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, 2013. e-Pub 2013.
82. Wang X, Salehpour M, Howell R, Melancon A, Sun T, Woodward WA, Smith B. Evaluation of Setup Uncertainties for Electron Boost Field Treated Using Compression Device for Breast Cancer Irradiation. Medical Physics 40(6), 2013. e-Pub 2013.
83. Dallas NA, Bedrosian I, Allen LR, Bloom ES, Shaitelman SF, Mittendorf EA, Woodward WA, Tereffe W, Kuerer HM, Hunt K, Alvarado R, Babiera G. Factors Associated with Non-Receipt of Accelerated Partial Breast Irradiation (APBI) in Early-Stage Breast Cancer. 66th Annual Cancer Symposium of the Society-of-Surgical-Oncology (SSO), 2013. e-Pub 2013.
84. Smith DL, Larson R, Kong F, Yang D, Woodward WA, Sims-Mourtada J. Molecular imaging of the hedgehog signaling pathway in breast cancer. AACR/SNMMI Conference on State-of-the-Art Molecular Imaging in Cancer Biology and Therapy, 2013. e-Pub 2013.
85. FitzSullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera G, Black S, Wagner JL, Bedrosian I, Woodward WA, Gainer SM, Hwang R, Meric-Bernstam F, Hunt K, Kuerer, HM. Incidence and Consequence of Close Margins for Ductal Carcinoma In Situ Treated with Mastectomy. 66th Annual Cancer Symposium of the Society-of-Surgical-Oncology (SSO), 2013. e-Pub 2013.
86. Lacerda L, Smith D, Debeb B, Solley T, Larson R, Xu W, Krishnamurthy S, Ueno N, Klopp A, Woodward WA. Mesenchymal stem cells promote tumor-skin involvement in inflammatory breast cancer models. Cancer Research 73, 2013. e-Pub 2013.
87. Masuda H, Iwamoto T, Brewer T, Hsu L, Kai K, Woodward WA, Reuben JM, Valero V, Alvarez RH, Willey J, Hortobagyi GN, Ueno NT. Response to neoadjuvant systemic therapy (NST) in inflammatory breast cancer (IBC) according to estrogen receptor (ER) and HER2 expression. Cancer Research 72, 2012. e-Pub 2012.
88. Debeb BG, Larson RA, Lacerda L, Xu W, Smith DL, Ueno NT, Reuben JM, Gilcrease M, Krishnamurthy S, Buchholz TA, Woodward WA. Histone deacetylase (HDAC)-inhibitor mediated reprogramming drives cancer cells to the pentose phosphate metabolic pathway. Cancer Research 72, 2012. e-Pub 2012.
89. Anfossi S, Giordano A, Cohen EN, Gao H, Woodward WA, Ueno NT, Valero V, Alvarez RH, Hortobagyi GN, Lee BN, Cristofanilli M, Reuben JM. High serum levels of miR-19a are associated with poor outcome in metastatic inflammatory breast cancer. Cancer Research 72, 2012. e-Pub 2012.
90. Xu W, Debeb BG, Smith DL, Li JL, Ueno NT, Alvarez DLC, Larson RA, Schwba LP, Seagroves TN, Woodward WA. HIF-1 alpha knockout radiosensitizes select Inflammatory Breast Cancer cells through reduction of stem-like cancer cells. Cancer Research 72, 2012. e-Pub 2012.
91. Krishnamurthy S, Woodward WA, Reuben JM, Tepperberg J, Ogura D, Niwa S, Ueno NT. Status of anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma. Cancer Research 72, 2012. e-Pub 2012.
92. Cohen EN, Gao H, Anfossi S, Giordano A, Tin S, Wu Q, Lee BN, Luthra R, Krishnamurthy S, Hortobagyi GN, Ueno NT, Woodward WA, Reuben JM. Soluble factors from activated immune cells induce epithelial mesenchymal transition in inflammatory breast cancer cells. Cancer Research 72, 2012. e-Pub 2012.
93. Lacerda L, Reddy J, Liu D, Larson R, Masuda H, Brewer T, Debeb B, Xu W, Hortobagyi GN, Buchholz TA, Ueno NT, Woodward WA. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with post-mastectomy radiation. Cancer Research 72, 2012. e-Pub 2012.
94. Reyes ME, Masuda H, Zhang D, Reuben JM, WA &, Darnay BG, Hortobagyl GN, Ueno NT. Receptor Activator of Nuclear Factor Kappa B (RANK) as a potential therapeutic target in triple-negative breast cancer. Cancer Research 72, 2012. e-Pub 2012.
95. Brewer TM, Masuda H, Iwamoto, Liu P, Shen Y, Liu DD, Kai K, Barnett CM, Woodward WA, Reuben JM, Yang P, Hortobagyi GN, Ueno NT. Statin use and improved outcome in primary inflammatory breast cancer: retrospective cohort study. Cancer Research 72, 2012. e-Pub 2012.
96. Giordano A, Gao H, Cohen EN, Anfossi S, Hess KR, Krishnamurthy S, Tin S, Cristofanilli M, Hortobagyi GN, Woodward WA, Ueno NT, Lucci A, Reuben JM. Identification of cancer stem cells (CD44+CD24-/lo) in bone marrow as a prognostic factor in early breast cancer patients. Cancer Research 72, 2012. e-Pub 2012.
97. Atkinson RL, Sexton KR, Ueno NT, El-Zein R, Brewster AM, Krishnamurthy SA, Woodward WA. Epidemiological risk factors and normal breast tissue markers in inflammatory breast cancer. Cancer Research 72, 2012. e-Pub 2012.
98. Woodward WA, Huo L, Li J, Sneige N, Gonzalez-Angulo AM, Debeb BG, Chang C, Hung M, Valero V, Ueno NT. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. Int J Radiat Oncol Biol Phys, Proceedings of ASTRO 84(3S):S714, 2012. e-Pub 2012.
99. Kim MM, Allen P, Gonzalez-Angulo A, Woodward WA, Meric-Bernstam F, Buzdar AU, Hunt KK, Hortobagyi GN, Buchholz TA, Mittendorf EA. Pathologic Complete Response to Neoadjuvant Chemotherapy Plus Trastuzumab Predicts for Improved Survival in Women With HER2-positive Breast Cancer. 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2012. e-Pub 2012.
100. Alvarez RH, Cristofanilli M, Enso J, Lucci A, Yang W, LePetross H, Reuben JM, Babiera G, Huo L, Gong Y, Woodward WA, Parker CA, Willey JS, MacEachern J, Buchholz TA, Ueno NT, Valero V. Limited efficacy and significant toxicities of Lapatinib (Lap) plus chemotherapy as neoadjuvant therapy (NAC) for HER2-positive inflammatory breast cancer (IBC) patients (Pts). Proceedings of the 2012 ASCO Annual Meeting, 2012. e-Pub 2012.
101. Masuda H, Baggerly K, Wang Y, Iwamoto T, Brewer T, Pusztai L, Kai K, Woodward WA, Reuben JM, Van Laere SJ, Bertucci F, Hortobagyi GN, Ueno NT. Molecular comparison of human triple-negative inflammatory breast cancer (TN-IBC) and human triple-negative noninflammatory breast cancer (TN-non-IBC). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2012. e-Pub 2012.
102. Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Lucci A, Bedrosian I, Kuerer HM, Hunt K, Huo L, Babiera G. Primary tumor resection to improve survival and local disease control in stage IV inflammatory breast cancer. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2012. e-Pub 2012.
103. de Lacerda LCA, Klopp AH, Garza RJ, Cohen EN, Solley TN, Li L, Debeb BG, Xu W, Reuben JM, Woodward WA. Impact of tumor microenvironment on expansion of tumor initiating cells in breast cancer metastasis. Cancer Research 72, 2012. e-Pub 2012.
104. Debeb BG, Xu W, Lacerda L, Li L, Wei CM, Reuben JM, Ueno NT, Buchholz TA, Woodward WA. Radiation modulates expression of microRNAs in breast cancer cell lines grown under adherent and stem cell promoting culture conditions. Cancer Research 72, 2012. e-Pub 2012.
105. Nowicka AK, Solley T, Sharp HJ, Marini FC, Broaddus R, Kolonin M, Mok S, Woodward WA, Lu KH, Klopp AH. Eavesdropping of crosstalk between adipose stem cells (ASC) and ovarian cancer cells. Cancer Research 72, 2012. e-Pub 2012.
106. Atkinson RL, Sexton K, Ueno NT, Krishnamurthy S, Woodward WA, El-Zein R, Brewster AM. Epidemiological Risk Factors Associated with Inflammatory Breast Cancer Triple Negative Subtype. 36th Annual Meeting of American-Society-of-Preventive-Oncology (ASPO), 2012. e-Pub 2012.
107. Debeb BG, Larson R, Xu W, Lacerda L, Reuben JM, Buchholz TA, Ueno NT, Woodward WA. The effect of surviving downregulation on radiosensitization of breast cancer cell lines grown under adherent and stem cell promoting culture conditions. Cancer Research 71(24):170s, 2011. e-Pub 2011.
108. Mego M, Giordano A, De Giogi U, Hsu L, Lucci A, Dawood S, Woodward WA, Ueno NT, Valero V, Andreopoulou E, Hortobagyi GN, Reuben JM, Cristofanilli M. Circulating tumor cells in newly diagnosed inflammatory breast cancer. Cancer Research 71(24):449s, 2011. e-Pub 2011.
109. Xu W, Debeb B, de Lacerda L, Li L, Larson R, Reuben J, Ueno N, Woodward WA. The mechanism of anti-breast cancer TICs effect of pyrvinium pamoate is through WNT/beta-catenin signaling. Cancer Research 71(24):170s, 2011. e-Pub 2011.
110. Wang X, Saso H, Iwamoto T, Pusztai L, Gong Y, Woodward WA, Reuben JM, Hortobagyi GN, Ueno NT. A novel inflammatory breast cancer-specific oncogene, Tazarotene-induced gene 1, promotes tumorigenicity and invasiveness through the receptor tyrosine kinase Axl. Cancer Research 71(24):255s, 2011. e-Pub 2011.
111. Gao H, Cohen EN, B-N L, Giordano A, Tin S, Anfossi S, Parker CA, Cristofanilli M, Valero V, Alvarez RH, Hortobagyi GN, Woodward WA, Ueno NT, Reuben JM. Cytokine synthesis by activated dendritic cells in relation to disease progression in inflammatory breast cancer (IBC). Cancer Research 71(24):511s, 2011. e-Pub 2011.
112. Cohen EN, Gao H, B-N L, Giordano A, Tin S, Anfossi S, Parker CA, Cristofanilli M, Valero V, Alvarez RH, Hortobagyi GN, Woodward WA, Ueno NT, Reuben JM. T-cell cytokine production related to progression of breast cancer patients. Cancer Research 71(24):511s, 2011. e-Pub 2011.
113. Van Laere SJ, Ueno NT, Finetti P, Vermeulen PB, Lucci A, Birnbaum D, Roberston FM, van Dam PA, Woodward WA, Viens P, Dirix LY, Reuben JM, Iwamoto T, Cristofanilli M, Bertucci F. An integrated analysis of three distinct IBC/nIBC affymetrix gene expression data sets further unveils the molecular biology of IBC. Cancer Research 71(24):124s, 2011. e-Pub 2011.
114. Amos R, Woodward WA. Field matching for combined proton, photon and electron post-mastectomy radiation therapy (PMRT) for breast cancer. Proceedings of the 49th International Conference of the Particle Therapy Co-Operative Group:p 212, 2010. e-Pub 2010.
115. Settle SH, Gonzalez-Angulo AM, Buchholz TA, Woodward WA, Tk Y, Oh JL, Sahin A, Meric-Bernstam F, Hortobagyi GN, Tereffe W. Local-regional outcomes in triple-negative breast cancer patients who receive breast conservation therapy. Oncology 24(4, S3):22, 2010. e-Pub 2010.
116. Walker GV, Smith GL, Allen P, Perkins GH, Oh JL, Woodward WA, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-based analysis of occult primary breast cancer with axillary nodal metastasis. Oncology 24(4, S3):2, 2010. e-Pub 2010.
117. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TA. Estrogen receptor (ER) positive, progesterone receptor (PR) negative or ER-PR+ breast cancer predicts locoregional recurrence but not distant metastases compared to ER+PR+ disease in patients with node-negative disease and tumors one centimeter or less. Oncology 24(4, S3):21, 2010. e-Pub 2010.
118. Yu TK, Carkaci S, Strom EA, Perkins GH, Tereffe W, Woodward WA, Oh JL, Rohren EM, Cristofanilli M, Yang WT, Buchholz TA. FDG-PET response of lymph nodes to neoadjuvant chemotherapy for locally advanced breast cancer does not correlate with pathologic response. Oncology 24(4, S3):1, 2010. e-Pub 2010.
119. Li C, Lee BN, Woodward WA, Ueno NT, Robertson F, Reuben JM, Cristofanilli M. p53 mutation in inflammatory breast cancer cell lines. Proceedings of The San Antonio Breast Cancer Symposium, 2009. e-Pub 2009.
120. Robertson RM, Woodward WA, Bornmann W, Player A, Ye Z, Cristofanilli M. The pan HDAC inhibitor suberoylanilide hydrozamic acid targets self renewal of breast cancer stem cells. Proceedings of The San Antonio Breast Cancer Symposium, 2009. e-Pub 2009.
121. Reuben JM, Lee BN, Lucci A, Gao H, Cohen EN, Li C, Krishnamurthy S, Hortobagyi HN, Woodward WA, Cristofanilli M. Disseminated tumor cells in primary breast cancer: Evaluation of the percentage of breast cancer stem cells in bone marrow aspirates of patients receiving neoadjuvant chemotherapy. Proceedings of ASCO, 2009. e-Pub 2009.
122. Debeb BG, Hall CS, Xu W, Ueno N, Reuben JM, Robertson F, Lucci A, Buchholz TA, Hortobagyi GN, Cristofanilli M, Woodward WA. Cancer initiating cells downregulate microRNAs implicated in the regulation of Epithelial Mesenchymal Transition (EMT). Proceedings of the American Association for Cancer Research:No. 7333, 2009. e-Pub 2009.
123. Woodward WA, Beadle BM, Meric-Bernstam F, Strom EA, Tereffe W, Yu TK, Oh JL, Perkins GH. Locoregional recurrence in young women with node-negative breast cancer treated with mastectomy, axillary lymph node evaluation and adjuvant chemotherapy. Oncology 23(4(S2)):4, 2009. e-Pub 2009.
124. Robertson F, Hall C, Bornmann W, Pal A, Peng Z, Woodward WA, Cristofanilli M. Targeting histone acetylase to inhibit the aggressive phenotype of human inflammatory breast cancer cells. Regulatory Networks in Stem Cells and Chromatin: Histones, Nucleaomsomes, Chromosomes and Genomes Conference, Singapore, 2009. e-Pub 2009.
125. Hall C, Woodward WA, Cristofanilli M, Robertson F. Mechanisms of transforming growth factor mediated invasion of inflammatory breast cancer stem cells. Regulatory Networks in Stem Cells and Chromatin: Histones, Nucleaomsomes, Chromosomes and Genomes Conferences, Singapore, 2009. e-Pub 2009.
126. Debeb BG, Hall CS, Xu W, Ueno NT, Reuben JM, Robertson F, Lucci A, Buchholz TA, Hortobagyi GN, Cristofanilli M, Woodward WA. Populations of cells exhibiting epithelial-mesenchymal transition (EMT) or stem cell characteristics can be propagated from a single inflammatory breast cancer (IBC) cell line based on culture conditions. Proceeding of The San Antonio Breast Cancer Symposium, 2008. e-Pub 2008.
127. Hall CS, Debeb BG, Xu W, Ueno NT, Reuben JM, Robertson F, Lucci A, Buchholz TA, Hortobagyi GN, Cristofanilli M, Woodward WA. Novel inflammatory breast cancer cell line, MDA- IBC-1 expresses and secretes WISP3, a putative tumor suppressor in inflammatory breast cancer. Proceedings of The San Antonio Breast Cancer Symposium, 2008. e-Pub 2008.
128. Singh B, Cook KR, Vincent L, Hall C, Martin C, Krishnamurthy S, Woodward WA, Cristofanilli M, Lucci A. Role of COX-2 in bone marrow micrometastasis and cancer initiating cell phenotype in breast cancer. Proceedings of The First International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
129. Gao H, Lucci A, Cohen EN, Lee BN, Li C, Krishnamurthy S, Andrepoulou E, De Giorgi U, Hortobagyi G, Cristofanilli M, Woodward WA, Reuben JM. Primary tumor size is associated with ALDH breast cancer initiating stem cells in bone marrow aspirate of primary breast cancer patients. The Proceedings of The First International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
130. Hall C, Debeb B, Xu W, Robertson F, Reuben JM, Ueno N, Cristofanilli M, Lucci A, Woodward WA. Novel inflammatory breast cancer cell line, MDA-IBC-1 expresses and secretes Wisp3 a putative tumor suppressor in inflammatory breast cancer. The Proceedings of The First International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
131. Lee BN, Li C, Lucci A, Cohen EN, Gao H, Krishnamurthy S, Ueno NT, Hortobagyi GN, Cristofanilli M, Woodward WA, Reuben JM. Notch-1 expressing cancer initiating cells in bone marrow aspirates of patients with primary breast cancer. Proceedings of The First International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
132. Gao H, Lucci A, Cohen EN, Lee BN, Li C, Krishnamurthy S, Andreopoulou E, De Giorgi U, Hortobagyi GN, Cristofanilli M, Woodward WA, Rueben JM. Primary tumor size is associated with ALDHbr breast cancer initiating stem cells in bone marrow aspirates of primary breast cancer patients. Proceedings of The San Antonio Breast Cancer Symposium, 2008. e-Pub 2008.
133. Cohen EN, Jimenez C, Gao H, Lee BN, Li C, Krishnamurthy S, Woodward WA, Andreopoulou E, Bethancourt DL, Hortobagyi GN, Cristofanilli M, Reuben JM. Immune cells from pleural fluid of patients with inflammatory breast cancer are immune competent. Proceedings of The First International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
134. Ueno NT, Kazansky A, LaFortune T, Lucci A, Krishnamurthy S, Hung MC, Hortobagyi GN, Woodward WA, Reuben JM, Robertson F, Cristofanilli M, Zhang D. Suppression of mesenchymal phenotype in inflammatory breast cancer by EGFR tyrosine kinase inhibitor erlotinib: A novel approach to suppressing metastasis. The Proceedings of The San Antonio Breast Cancer Symposium, 2008. e-Pub 2008.
135. Debeb BG, Hall CS, Xu W, Ueno N, Reuben JM, Robertson F, Lucci A, Buchholz TA, Hortobagyi G, Cristofanilli M, Woodward WA. Populations of cells exhibiting epithelial-mesenchymal transition (EMT) and stem cell characteristics can be propagated from an inflammatory breast cancer (IBC) cell line. Proceedings of The First International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
136. Robertson F, Hall CS, Bornmann W, Pal A, Peng Z, Woodward WA, Cristofanilli M. Targeting histone acetylase to inhibit the aggressive phenotype of human inflammatory breast cancer cells. Proceedings of The First International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
137. Cohen EN, Jimenez C, Gao H, Lee BN, Li C, Krishnamurthy S, Woodward WA, Andreopoulou E, Bethancourt DL, Hortobagyi GN, Cristofanilli M, Reuben JM. Immune cells from pleural fluids of patients with inflammatory breast cancer are immune competent. Proceedings of The San Antonio Breast Cancer Symposium, 2008. e-Pub 2008.
138. Klostergaard J, Bankson J, Woodward WA, Seeney CE. Magnetic localization of magnetically-responsive nanoparticles to orthotopic human IBC xenografts. Proceedings of The First International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
139. Lee BN, Li C, Lucci A, Cohen EN, Gao H, Krishnamurthy S, Ueno NT, Hortobagyi GN, Cristofanilli M, Woodward WA, Reuben JM. Notch-1 expression is not related to the percentage of cd326+ cells in bone marrow aspirates of patients with primary breast cancer. The Proceedings of The San Antonio Breast Cancer Symposium, 2008. e-Pub 2008.
140. Xu W, Li J, Reuben JM, Krishnamurthy S, Cristofanilli M, Woodward WA. HIF1a is upregulated by radiation in breast cancer stem/tumor-initiating cells. Proceedings of The First International Inflammatory Breast Cancer Conference, 2008. e-Pub 2008.
141. Robertson F, Simeone AM, Lucci A, Woodward WA, Reuben J, Ueno N, Cristofanilli M. Role of the prostaglandin receptor EP3 in regulating vasculogenic mimicry of inflammatory breast cancer. The Proceedings of The San Antonio Breast Cancer Symposium, 2008. e-Pub 2008.
142. Woodward WA, Beadle BM, Oh JL, Tereffe W, Litton JK, Perkins GH, Strom EA, Yu T, Meric-Bernstam F, Buchholz T. Significant improvement in regional recurrence in young patients with breast cancer treated with comprehensive nodal irradiation. Proceedings of the American Society for Therapeutic Radiology and Oncology, Int J Radiat Oncol Biol Phys 72(1):S89, 2008. e-Pub 2008.
143. Xu W, Debeb BG, Hall C, Li J, Reuben J, Krishnamurthy S, Cristofanilli M, Woodward WA. HIF1a is up-regulated by radiation in breast cancer stem/tumor-initiating cells. Proceedings from the 50th Annual ASTRO Meeting, 2008. e-Pub 2008.
144. Perkins GH, Middleton LP, Tran R, Garcia SM, Cristofanilli M, Pusztai L, Singletary SE, Strom EA, Woodward WA, Yu TK, Oh JL, Tereffe W, Whitman GJ, Huang E, Allen PK, Buchholz TA. Concurrent chemoradiation with capecitabine achieves meritable response and local control for inoperable and recurrent neoadjuvant chemotherapy refractory breast cancer. Proceedings of the 2007 San Antonio Breast Cancer Symposium, 2007. e-Pub 2007.
145. Woodward WA, Reuben J, Gao H, Krishnamurthy S, Lucci A, Singh B, Li L, Cristofanilli M. Preliminary characterization and in vitro propagation of putative stem/progenitor cells from human inflammatory breast cancer. Proceedings of the San Antonio Breast Cancer Symposium, 2007. e-Pub 2007.
146. Woodward WA, Arriaga L, Domain D, Strom EA, Perkins GH, Yu TK, Oh JL, Tereffe W, Lucci A, Buchholz TA. Prospective evaluation of late, chronic lymphedema (LE) after axillary lymph node dissection (ALND) and comprehensive irradiation. Oncology 21(5)S2:9, 2007. e-Pub 2007.
147. Oh JL, Symman WF, Woodward WA, Tereffe W, Yu TK, Strom EA, Perkins GH, Buchholz TA. Pathologic response to neoadjuvant chemotherapy and radiation therapy to improve locoregional control. Oncology 21(5)S2:8, 2007. e-Pub 2007.
148. Oh JL, Nguyen G, Whitman GJ, Hunt KK, Woodward WA, Yu T, Tereffe W, Strom EA, Perkins GH, Buchholz TA. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy improves local control. Int J Radiat Oncol Biol Phys 69(3):S71-S72, 2007. e-Pub 2007.
149. Reed V, Woodward WA, Zhang L, Strom E, Perkins G, Tereffe W, Yu T, Oh J, Whitman J, Dong L. Delineating whole breast contouring variation using standard planning tools versus deformable image registration. Int J Radiat Oncol Biol Phys 69(3):S139-S140, 2007. e-Pub 2007.
150. Li XA, Arthur DW, Buchholz TA, MacDonald A, Marks LB, Pierce LJ, Taghian AG, Vicini FA, Woodward WA, White JA. Variability of target and normal structure delineation for breast-cancer radiotherapy: a RTOG Multi-Institutional and Multi-Observer Study. Int J Radiat Oncol Biol Phys 69(3):S72-S73, 2007. e-Pub 2007.
151. Smith GL, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, Perkins GH, Oh JL, Tereffe W, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 69(3):S217-S218, 2007. e-Pub 2007.
152. Beadle BM, Woodward WA, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu T, Meric-Bernstam F, Buchholz TA. Locoregional recurrence rates in young women with breast cancer by treatment approach. Int J Radiat Oncol Biol Phys 69(3):S213, 2007. e-Pub 2007.
153. Greenbaum MP, Strom EA, Allen PK, Perkins GH, Oh JL, Tereffe W, Yu KT, Buchholz TA, Woodward WA. Locoregional recurrence (LRR) before and after implementation of computed tomography (CT)-based treatment planning in post-mastectomy radiation therapy (PMRT). Int J Radiat Oncol Biol Phys 69(3):S223-S224, 2007. e-Pub 2007.
154. Woodward WA, Domain D, Tereffe W, Strom EA, Perkins GH, T-K Y, Oh JL, Buchholz TA. Locoregional recurrence after mastectomy and doxorubicin-based chemotherapy: 15-year update of The University of Texas M. D. Anderson Cancer Center experience. Proceedings of the San Antonio Breast Cancer Symposium, 2006. e-Pub 2006.
155. Woodward WA, Truong PT, Thames HD, Olivotto IA, Ragaz J, Buchholz TA. Using the nodal ratio of positive/excised nodes rather than the absolute number of positive lymph nodes minimizes differences in postmastectomy LRR risk between the British Columbia (BC) and The University of Texas M. D. Anderson Cancer Center (MDACC) prospective data sets. Proceedings of the 2006 Annual ASTRO Conference, 2006. e-Pub 2006.
156. Woodward WA, Giordano SH, Duan Z, Hortobagyi GN, Buchholz TA. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Cancer 106(12):2556-2562, 2006. e-Pub 2006.
157. Woodward WA, Oh JL, Strom EA, Perking GH, Levy LB, Buchholz TA. Maximizing curative potential for patients with isolated supraclavicular nodal recurrence after mastectomy and doxorubicin-based chemotherapy for breast cancer. Proceedings of the American Radium Society 48, 2005. e-Pub 2005.
158. Woodward WA, Sulman EP, Cox JD, Buchholz TA. Adjectives used in letters of recommendation to radiation oncology residency differ by applicant gender. Proceedings of the American Radium Society, 2005. e-Pub 2005.
159. Woodward WA, Durand J, Tucker SL, Strom EA, Perking GH, Oh JL, Arriaga L, Domain D, Buchholz TA. Prospective analysis of carotid flow in breast cancer patients treated with supraclavicular irradiation eight or more years prior to study: no increase in ipsilateral carotid stenosis after radiation. Int J Rad Oncol Biol Phys 63(2):S236, 2005. e-Pub 2005.
160. Truong PT, Cserni G, Woodward WA, Janni W, Tai P, Vlastos G, Working Group VVOBOTINR. Axillary lymph node ration in micrometastatic node-positive breast cancer. Proceedings of the San Antonio Breast Cancer Symposium, 2005. e-Pub 2005.
161. Royce M, S-J L, Wallace AM, Woodward WA, Ueno NT, Vinh-Hung V, Working Group ATINR. Lymph node ratio (LNR) is better survival predictor than conventional nodal categories: A Surveillance, Epidemiology, and End Results (SEER) database analysis fornode-positive breast cancer (BC). Proceedings of the San Antonio Breast Cancer Symposium, 2005. e-Pub 2005.
162. Woodward WA. Prospective analysis of carotid flow in breast cancer patients treated with supraclavicular irradiation eight or more years prior to study: No increase in ipsilateral carotid stenosis after radiation. Proceedings of the American Radium Society, 2005. e-Pub 2005.
163. Woodward WA, Levy LB, Thames HT, Lee AK, Cheung R, Kuban DL. Does Radiation Dose Affect Outcome for Prostate Cancer Patients Receiving Adjuvant Hormone Therapy? . Proc Am Radium Soc, 2004. e-Pub 2004.
164. Woodward WA, Chen M, Buchholz TA, Rosen J. Increased radiation resistance of mouse mammary side population stem/progenitor cells: role of Wnt/Beta-catenin signaling. Int J Rad Oncol Biol Phys, ASTRO, 2004. e-Pub 2004.
165. Buchholz TA, Woodward WA, Tucker SL, Strom EA, Hunt KK, Buzdar AU, Perkins GH, Schechter NR, Hortobagyi GN. Defining the competing risk of local-regional and distant recurrence in 1256 patients treated with mastectomy and doxorubicin-based adjuvant chemotherapy. Am Soc Clin Oncol Proc 23:23, 2004. e-Pub 2004.
166. Woodward WA, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Buchholz TA. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Proc Am Radium Soc 7:18, 2003. e-Pub 2003.
167. Woodward WA, Strom EA, McNeese MD, Singletary SE, Tucker SL, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA. Changes to the 2002 AJCC (American Joint Commission of Cancer) staging system dramatically improve the stage-specific survival of breast cancer patients. Am Soc Clin Oncol 17:22, 2003. e-Pub 2003.
168. Woodward WA, Katz A, Buchholz T, McNeese M, Perkins G, Jhingran A, Strom E. Patterns and predictors of locoregional recurrence in 469 patients treated with postmastectomy radiation. Int J Rad Oncol Biol Phys 54:91-92, 2002. e-Pub 2002.
169. Behda MC, Merola JS, Woodward WA, Vasudevan VJ, Gibson HW. Crystal structures of 30-crown-10 and its tetrahydrate. J Org Chem 59(7):1694-1702, 1994. e-Pub 1994.
170. Gadde M, Phillips C, Rahal O, Woodward W, Rylander M, Yankeelov T. An in vitro microfluidic tumor platform for modeling and investigating tumor stromal interactions in inflammatory breast cancer.
171. Whisenant M, Alexander A, Williams LA, Woodward WA, El-Zein R, Tada Ueno N. Establishing the content domain for a patient-reported outcomes measure to evaluate the unique symptom burden of inflammatory breast cancer.
172. Alexander A, Fujii T, Stauder MC, Woodward WA, Reuben JM, Shen Y, Liu D, Reddy SM, Valero V, Gilchrist SC, Lim B, Lucci A, Ueno NT, Barcenas CH. A pilot study to examine the feasibility of measuring CTC and inflammatory biomarker changes resulting from atorvastatin as adjuvant therapy in TNBC and TN-IBC patients with residual disease after neoadjuvant chemotherapy.
173. Balema W, Larson R, Van Whye R, Ye R, Ning J, Rahal O, Stecklein S, Krishnamurthy S, El-Zein R, Woodward WA. Modeling limited breastfeeding and diet on IBC like tumor progression.
174. Mason G, Overmoyer BA, Woodward WA, Badve S, Schneider RJ, Jagsi R, Lang JE, Alpaugh M, Smith K, Miller K. Inflammatory breast cancer (IBC) defined: Proposed common diagnostic criteria and scoring - Moving beyond the subjective ‘clinical diagnosis’ of IBC to advance research.
175. Kida K, Hess KR, Lim B, Iwase T, Chainitikun S, Sapon ME, Valero V, Lucci A, Le-Petross C, Woodward WA, Krishnamurthy S, Hortobagyi GN, Tripathy D, Ueno NT. Validation of prognostic stage and anatomic stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer. P5-06-10. Validation of prognostic stage and anatomic stage in the American joint committee on cancer 8th edition for inflammatory breast cancer.
176. Rahal O, Yang J, Li L, Larson R, Van Laere S, Ueno N, Sulman E, Woodward WA. Transcriptome analysis of patient derived xenograft mouse models of inflammatory breast cancer to gain insights into the contribution of tumor microenvironment.
177. Hu X, Villodre ES, Larson R, Rahal O, Wang X, Krishnamurthy S, Tripathy D, Ueno NT, Woodward WA, Debeb BG. Decorin-mediated suppression of tumorigenesis and skin invasion in inflammatory breast cancer via inhibition of the E-cadherin/EGFR axis.
178. Schlee Villodre E, Hu X, Larson R, Eckhardt BL, Gong Y, Huo L, Song J, Krishnamurthy S, Ibrahim N, Ueno NT, Tripathy D, Woodward WA, Debeb BG. Ndrg1-egfr axis in inflammatory breast cancer tumorigenesis and brain metastasis.

Book Chapters

1. Corrigan KL, Woodward WA. Inflammatory/Recurrent Breast Cancer. In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology. 2nd, 2023.
2. Corrigan KL, Woodward WA. General Breast Cancer. In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology. 2nd, 2023.
3. Corrigan KL, Woodward WA. Early-Stage Breast Cancer. In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology. 2nd, 2023.
4. Corrigan KL, Woodward WA. Ductal Carcinoma In Situ. In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology. 2nd, 2023.
5. Corrigan KL, Woodward WA. Locally Advanced Breast Cancer. In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology. 2nd, 2023.
6. Le-Petross, H, Stafford, RJ, Bedrosian, I, Garvey, PB, Woodward, W, Moulder-Thompson, SL. Breast Cancer, 476-502, 2022.
7. Woodward, W. Working with colleagues and staff, 131-143, 2021.
8. Woodward, W, Poenisch, F, Hoffman, K. Proton radiotherapy for breast cancer, 115-125, 2020.
9. Reddy JP, Woodward WA. Early-Stage Breast Cancer (ESBC). In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology, 2020.
10. Logan J, Woodward WA. Locally Advanced Breast Cancer (LABC). In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology, 2020.
11. Frank SJ, X Ronald Zhu X. Proton Radiotherapy for Breast Cancer. In: Proton Therapy, 1st Edition. 1. Elsevier, 116-125, 2020.
12. Moreno AC, Woodward WA. General Breast Cancer. In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology, 2020.
13. Woodward WA, Poenisch F, Hoffman K. Proton Radiotherapy for Breast Cancer. In: Proton Therapy, Indications, Techniques and Outcomes. 1. Elsevier, 272, 2020.
14. Logan J, Woodward WA. Inflammatory/Recurrent Breast Cancer. In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology, 2020.
15. Moreno AC, Woodward WA. Ductal Carcinoma In Situ (DCIS). In: Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology, 2020.
16. Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, Ueno NT, Lim B. Inflammatory Breast Cancer: What to know about this unique, aggressive Breast Cancer. In: Management of Breast Cancer. Elsevier, 2018.
17. Woodward WA, Hill RP. Cancer Stem Cells. In: Molecular Radio-Oncology. Springer-Verlag Berlin Heidelberg, 25-44, 2016.
18. Woodward WA, Lim B, Stauder MC, Lucci A, Ueno NT. Inflammatory breast cancer. In: Hunt KK Robb GL, Strom EA, Ueno NT. In: eds. Breast Cancer, 3rd ed. New York: Springer, 2016.
19. Woodward, W, Hill, RP. Cancer stem cells, 25-44, 2016.
20. Woodward WA, Stauder MC, Perez EA. Locoregional treatment of the patient with inflammatory breast cancer. In: Current Breast Cancer Reports. In: Current Breast Cancer Reports. 1, 37-42, 2015.
21. Woodward WA. Cell gene Expression signatures in inflammatory breast cancer. In: Inflammatory Breast Cancer: An Update. Springer, Dordrecht, 259-270, 2012.
22. Gilcrease MZ, Babiera GV, Hennessy BT, Woodward WA. Metaplastic Carcinoma of the Breast. In: Advanced Therapy of Breast Disease, Third Edition. Third. People's Medical Publishing House, 1119-1132, 2012.
23. Buchholz TA, Bristol I, Woodward WA. Radiation Therapy for Inflammatory Breast Cancer. In: Inflammatory Breast Cancer: An Update. Springer, Dordrecht, 75-84, 2012.
24. Lacerda L, Woodward WA. Models of Inflammatory Breast Cancer. In: Inflammatory Breast Cancer: An Update. Springer, Dordrecht, 139-150, 2012.
25. Le-Petross H, Stafford RJ, Bedrosian I, Garvey PB, Woodward WA, Moulder-Thompson SL. Breast cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier Health Sciences, 479-507, 2012.
26. Woodward WA, Cox JD. Molecular basis of radiation therapy. In: The Molecular Basis of Cancer. 3rd. WB Saunders Co, 593-604, 2008.
27. DeLise AM, Stringa E, Woodward WA Mello MA, Tuan RS. Embryonic limb mesenchyme micromass culture as an in vitro Model for chondrogenesis and cartilage maturation. In: Methods Mol Biol. 3. Humana Press, 359-375, 2000.

Books (edited and written)

1. Kronowitz SJ, Benson JR, Nava MB. Oncoplastic and Reconstructive Management of the Breast, Third Edition. Ed(s) 3. CRC Press, 2020.
2. Tang C, Farooqi A. Pocket Radiation Oncology: The MD Anderson Cancer Center Handbook of Radiation Oncology, 2020.

Letters to the Editor

1. Woodward WA, Ueno NT, Kuerer HM, Lucci A, Shen Y. Reply to 'A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18'. Breast 39: 148-149, 2018.
2. Woodward WA, Lucci A, Cristofanilli M. Reply to Dr. Liu re: A gene signature in breast cancer. NEJM 356(18): 1887-1888, 2007.
3. Woodward WA, Garg A, Buchholz TA. Reply to Dr. Mourson. Int J Radiat Oncol Biol Phys 60: 687, 2004.
4. Woodward WA, Buchholz TA. Reply to Drs Madhavan and Perez. Int J Radiat Oncol Biol Phys 59: 320, 2004.